EP3710580A1 - Alpha-amylase, composition and method - Google Patents
Alpha-amylase, composition and methodInfo
- Publication number
- EP3710580A1 EP3710580A1 EP18807505.5A EP18807505A EP3710580A1 EP 3710580 A1 EP3710580 A1 EP 3710580A1 EP 18807505 A EP18807505 A EP 18807505A EP 3710580 A1 EP3710580 A1 EP 3710580A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- polypeptide
- glucose
- starch
- alpha
- amylase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims abstract description 123
- 108090000637 alpha-Amylases Proteins 0.000 title claims abstract description 118
- 102000004139 alpha-Amylases Human genes 0.000 title claims abstract description 104
- 229940024171 alpha-amylase Drugs 0.000 title claims abstract description 73
- 239000000203 mixture Substances 0.000 title claims abstract description 35
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 126
- 102000004196 processed proteins & peptides Human genes 0.000 claims abstract description 125
- 229920001184 polypeptide Polymers 0.000 claims abstract description 123
- 230000000694 effects Effects 0.000 claims abstract description 79
- 229920002472 Starch Polymers 0.000 claims description 128
- 235000019698 starch Nutrition 0.000 claims description 126
- 239000008107 starch Substances 0.000 claims description 125
- 102000004190 Enzymes Human genes 0.000 claims description 97
- 108090000790 Enzymes Proteins 0.000 claims description 97
- 229940088598 enzyme Drugs 0.000 claims description 97
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 71
- 238000000855 fermentation Methods 0.000 claims description 60
- 230000004151 fermentation Effects 0.000 claims description 60
- 102100022624 Glucoamylase Human genes 0.000 claims description 53
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 51
- 239000008103 glucose Substances 0.000 claims description 51
- 239000000758 substrate Substances 0.000 claims description 49
- 108010073178 Glucan 1,4-alpha-Glucosidase Proteins 0.000 claims description 42
- 230000008569 process Effects 0.000 claims description 34
- 102000040430 polynucleotide Human genes 0.000 claims description 32
- 108091033319 polynucleotide Proteins 0.000 claims description 32
- 239000002157 polynucleotide Substances 0.000 claims description 32
- 150000001413 amino acids Chemical group 0.000 claims description 29
- 239000013598 vector Substances 0.000 claims description 29
- -1 perhydrolase Proteins 0.000 claims description 28
- 230000014509 gene expression Effects 0.000 claims description 25
- 238000004519 manufacturing process Methods 0.000 claims description 24
- 239000007787 solid Substances 0.000 claims description 23
- 239000002253 acid Substances 0.000 claims description 21
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 21
- 150000001720 carbohydrates Chemical class 0.000 claims description 19
- 239000006188 syrup Substances 0.000 claims description 18
- 235000020357 syrup Nutrition 0.000 claims description 18
- 108010019077 beta-Amylase Proteins 0.000 claims description 17
- 239000000463 material Substances 0.000 claims description 17
- 108091005804 Peptidases Proteins 0.000 claims description 16
- 239000004365 Protease Substances 0.000 claims description 16
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 16
- 239000007795 chemical reaction product Substances 0.000 claims description 15
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 14
- 244000005700 microbiome Species 0.000 claims description 14
- 235000019419 proteases Nutrition 0.000 claims description 13
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 claims description 12
- RRHGJUQNOFWUDK-UHFFFAOYSA-N Isoprene Chemical compound CC(=C)C=C RRHGJUQNOFWUDK-UHFFFAOYSA-N 0.000 claims description 12
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 12
- 238000012217 deletion Methods 0.000 claims description 12
- 230000037430 deletion Effects 0.000 claims description 12
- 238000006467 substitution reaction Methods 0.000 claims description 12
- 108010011619 6-Phytase Proteins 0.000 claims description 11
- 229940085127 phytase Drugs 0.000 claims description 11
- 108091026890 Coding region Proteins 0.000 claims description 10
- 108090000371 Esterases Proteins 0.000 claims description 10
- 108090001060 Lipase Proteins 0.000 claims description 10
- 102000004882 Lipase Human genes 0.000 claims description 10
- 239000004367 Lipase Substances 0.000 claims description 10
- 244000061456 Solanum tuberosum Species 0.000 claims description 10
- 235000002595 Solanum tuberosum Nutrition 0.000 claims description 10
- 102000004357 Transferases Human genes 0.000 claims description 10
- 108090000992 Transferases Proteins 0.000 claims description 10
- 108010002430 hemicellulase Proteins 0.000 claims description 10
- 235000019421 lipase Nutrition 0.000 claims description 10
- 229940040461 lipase Drugs 0.000 claims description 10
- 108010028688 Isoamylase Proteins 0.000 claims description 9
- 108010005400 cutinase Proteins 0.000 claims description 9
- 230000028327 secretion Effects 0.000 claims description 9
- 101710121765 Endo-1,4-beta-xylanase Proteins 0.000 claims description 8
- 240000003183 Manihot esculenta Species 0.000 claims description 8
- 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 claims description 8
- 102000004316 Oxidoreductases Human genes 0.000 claims description 8
- 108090000854 Oxidoreductases Proteins 0.000 claims description 8
- 108010059820 Polygalacturonase Proteins 0.000 claims description 8
- 244000062793 Sorghum vulgare Species 0.000 claims description 8
- 108700040099 Xylose isomerases Proteins 0.000 claims description 8
- 108010093305 exopolygalacturonase Proteins 0.000 claims description 8
- 238000003780 insertion Methods 0.000 claims description 8
- 230000037431 insertion Effects 0.000 claims description 8
- 239000004310 lactic acid Substances 0.000 claims description 8
- 235000014655 lactic acid Nutrition 0.000 claims description 8
- 108010059892 Cellulase Proteins 0.000 claims description 7
- 230000003197 catalytic effect Effects 0.000 claims description 7
- 229940106157 cellulase Drugs 0.000 claims description 7
- 235000015165 citric acid Nutrition 0.000 claims description 7
- 229940059442 hemicellulase Drugs 0.000 claims description 7
- 239000002773 nucleotide Substances 0.000 claims description 7
- 125000003729 nucleotide group Chemical group 0.000 claims description 7
- DNIAPMSPPWPWGF-VKHMYHEASA-N (+)-propylene glycol Chemical compound C[C@H](O)CO DNIAPMSPPWPWGF-VKHMYHEASA-N 0.000 claims description 6
- 229940035437 1,3-propanediol Drugs 0.000 claims description 6
- YPFDHNVEDLHUCE-UHFFFAOYSA-N 1,3-propanediol Substances OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 claims description 6
- AEQDJSLRWYMAQI-UHFFFAOYSA-N 2,3,9,10-tetramethoxy-6,8,13,13a-tetrahydro-5H-isoquinolino[2,1-b]isoquinoline Chemical compound C1CN2CC(C(=C(OC)C=C3)OC)=C3CC2C2=C1C=C(OC)C(OC)=C2 AEQDJSLRWYMAQI-UHFFFAOYSA-N 0.000 claims description 6
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 claims description 6
- 240000005979 Hordeum vulgare Species 0.000 claims description 6
- 235000007340 Hordeum vulgare Nutrition 0.000 claims description 6
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims description 6
- 239000004472 Lysine Substances 0.000 claims description 6
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims description 6
- HLCFGWHYROZGBI-JJKGCWMISA-M Potassium gluconate Chemical compound [K+].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O HLCFGWHYROZGBI-JJKGCWMISA-M 0.000 claims description 6
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims description 6
- 150000007513 acids Chemical class 0.000 claims description 6
- 108010047754 beta-Glucosidase Proteins 0.000 claims description 6
- 102000006995 beta-Glucosidase Human genes 0.000 claims description 6
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 claims description 6
- 239000004227 calcium gluconate Substances 0.000 claims description 6
- 235000013927 calcium gluconate Nutrition 0.000 claims description 6
- 229960004494 calcium gluconate Drugs 0.000 claims description 6
- NEEHYRZPVYRGPP-UHFFFAOYSA-L calcium;2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Ca+2].OCC(O)C(O)C(O)C(O)C([O-])=O.OCC(O)C(O)C(O)C(O)C([O-])=O NEEHYRZPVYRGPP-UHFFFAOYSA-L 0.000 claims description 6
- 239000000174 gluconic acid Substances 0.000 claims description 6
- 235000012208 gluconic acid Nutrition 0.000 claims description 6
- 229950006191 gluconic acid Drugs 0.000 claims description 6
- LPUQAYUQRXPFSQ-DFWYDOINSA-M monosodium L-glutamate Chemical compound [Na+].[O-]C(=O)[C@@H](N)CCC(O)=O LPUQAYUQRXPFSQ-DFWYDOINSA-M 0.000 claims description 6
- 239000004223 monosodium glutamate Substances 0.000 claims description 6
- 235000013923 monosodium glutamate Nutrition 0.000 claims description 6
- 229920000166 polytrimethylene carbonate Polymers 0.000 claims description 6
- 239000004224 potassium gluconate Substances 0.000 claims description 6
- 235000013926 potassium gluconate Nutrition 0.000 claims description 6
- 229960003189 potassium gluconate Drugs 0.000 claims description 6
- 239000004320 sodium erythorbate Substances 0.000 claims description 6
- 235000010352 sodium erythorbate Nutrition 0.000 claims description 6
- 239000000176 sodium gluconate Substances 0.000 claims description 6
- 235000012207 sodium gluconate Nutrition 0.000 claims description 6
- 229940005574 sodium gluconate Drugs 0.000 claims description 6
- RBWSWDPRDBEWCR-RKJRWTFHSA-N sodium;(2r)-2-[(2r)-3,4-dihydroxy-5-oxo-2h-furan-2-yl]-2-hydroxyethanolate Chemical compound [Na+].[O-]C[C@@H](O)[C@H]1OC(=O)C(O)=C1O RBWSWDPRDBEWCR-RKJRWTFHSA-N 0.000 claims description 6
- JAHNSTQSQJOJLO-UHFFFAOYSA-N 2-(3-fluorophenyl)-1h-imidazole Chemical compound FC1=CC=CC(C=2NC=CN=2)=C1 JAHNSTQSQJOJLO-UHFFFAOYSA-N 0.000 claims description 5
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 5
- PHOQVHQSTUBQQK-SQOUGZDYSA-N D-glucono-1,5-lactone Chemical compound OC[C@H]1OC(=O)[C@H](O)[C@@H](O)[C@@H]1O PHOQVHQSTUBQQK-SQOUGZDYSA-N 0.000 claims description 5
- 235000011684 Sorghum saccharatum Nutrition 0.000 claims description 5
- 235000021307 Triticum Nutrition 0.000 claims description 5
- 239000003225 biodiesel Substances 0.000 claims description 5
- CYQFCXCEBYINGO-IAGOWNOFSA-N delta1-THC Chemical compound C1=C(C)CC[C@H]2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3[C@@H]21 CYQFCXCEBYINGO-IAGOWNOFSA-N 0.000 claims description 5
- 235000012209 glucono delta-lactone Nutrition 0.000 claims description 5
- 239000000182 glucono-delta-lactone Substances 0.000 claims description 5
- 229960003681 gluconolactone Drugs 0.000 claims description 5
- LVHBHZANLOWSRM-UHFFFAOYSA-N methylenebutanedioic acid Natural products OC(=O)CC(=C)C(O)=O LVHBHZANLOWSRM-UHFFFAOYSA-N 0.000 claims description 5
- 235000019713 millet Nutrition 0.000 claims description 5
- 229940012843 omega-3 fatty acid Drugs 0.000 claims description 5
- 235000020660 omega-3 fatty acid Nutrition 0.000 claims description 5
- 150000007524 organic acids Chemical class 0.000 claims description 5
- ZIIUUSVHCHPIQD-UHFFFAOYSA-N 2,4,6-trimethyl-N-[3-(trifluoromethyl)phenyl]benzenesulfonamide Chemical compound CC1=CC(C)=CC(C)=C1S(=O)(=O)NC1=CC=CC(C(F)(F)F)=C1 ZIIUUSVHCHPIQD-UHFFFAOYSA-N 0.000 claims description 4
- 108010003272 Hyaluronate lyase Proteins 0.000 claims description 4
- 102000001974 Hyaluronidases Human genes 0.000 claims description 4
- 102000004157 Hydrolases Human genes 0.000 claims description 4
- 108090000604 Hydrolases Proteins 0.000 claims description 4
- 244000017020 Ipomoea batatas Species 0.000 claims description 4
- 235000002678 Ipomoea batatas Nutrition 0.000 claims description 4
- 108010029541 Laccase Proteins 0.000 claims description 4
- 102000003820 Lipoxygenases Human genes 0.000 claims description 4
- 108090000128 Lipoxygenases Proteins 0.000 claims description 4
- 102000003992 Peroxidases Human genes 0.000 claims description 4
- 108010064785 Phospholipases Proteins 0.000 claims description 4
- 102000015439 Phospholipases Human genes 0.000 claims description 4
- 108700019535 Phosphoprotein Phosphatases Proteins 0.000 claims description 4
- 102000045595 Phosphoprotein Phosphatases Human genes 0.000 claims description 4
- 235000007238 Secale cereale Nutrition 0.000 claims description 4
- 102000003425 Tyrosinase Human genes 0.000 claims description 4
- 108060008724 Tyrosinase Proteins 0.000 claims description 4
- 125000003158 alcohol group Chemical group 0.000 claims description 4
- YERABYSOHUZTPQ-UHFFFAOYSA-P endo-1,4-beta-Xylanase Chemical compound C=1C=CC=CC=1C[N+](CC)(CC)CCCNC(C(C=1)=O)=CC(=O)C=1NCCC[N+](CC)(CC)CC1=CC=CC=C1 YERABYSOHUZTPQ-UHFFFAOYSA-P 0.000 claims description 4
- 239000012634 fragment Substances 0.000 claims description 4
- 229960002773 hyaluronidase Drugs 0.000 claims description 4
- 108010059345 keratinase Proteins 0.000 claims description 4
- 230000002366 lipolytic effect Effects 0.000 claims description 4
- 108010087558 pectate lyase Proteins 0.000 claims description 4
- 229940072417 peroxidase Drugs 0.000 claims description 4
- 108040007629 peroxidase activity proteins Proteins 0.000 claims description 4
- 238000012545 processing Methods 0.000 claims description 4
- 108010038851 tannase Proteins 0.000 claims description 4
- 102100032487 Beta-mannosidase Human genes 0.000 claims description 3
- 102000005548 Hexokinase Human genes 0.000 claims description 3
- 108700040460 Hexokinases Proteins 0.000 claims description 3
- 108010055059 beta-Mannosidase Proteins 0.000 claims description 3
- 230000004481 post-translational protein modification Effects 0.000 claims description 3
- 108010087967 type I signal peptidase Proteins 0.000 claims description 3
- 102100029677 Trehalase Human genes 0.000 claims description 2
- 108010087472 Trehalase Proteins 0.000 claims description 2
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims 3
- 108010023736 Chondroitinases and Chondroitin Lyases Proteins 0.000 claims 2
- 102000011413 Chondroitinases and Chondroitin Lyases Human genes 0.000 claims 2
- 240000006394 Sorghum bicolor Species 0.000 claims 2
- 108010084650 alpha-N-arabinofuranosidase Proteins 0.000 claims 2
- 108010062085 ligninase Proteins 0.000 claims 2
- 235000009430 Thespesia populnea Nutrition 0.000 claims 1
- 244000098338 Triticum aestivum Species 0.000 claims 1
- 210000004027 cell Anatomy 0.000 description 89
- 108090000623 proteins and genes Proteins 0.000 description 62
- 108010065511 Amylases Proteins 0.000 description 61
- 102000013142 Amylases Human genes 0.000 description 60
- 235000019418 amylase Nutrition 0.000 description 60
- 239000004382 Amylase Substances 0.000 description 48
- 102000004169 proteins and genes Human genes 0.000 description 39
- 235000018102 proteins Nutrition 0.000 description 36
- 229940024606 amino acid Drugs 0.000 description 25
- 230000002538 fungal effect Effects 0.000 description 24
- 150000007523 nucleic acids Chemical class 0.000 description 24
- 239000000047 product Substances 0.000 description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 22
- 108020004414 DNA Proteins 0.000 description 21
- 125000003275 alpha amino acid group Chemical group 0.000 description 21
- 102000039446 nucleic acids Human genes 0.000 description 20
- 108020004707 nucleic acids Proteins 0.000 description 20
- 229910001868 water Inorganic materials 0.000 description 20
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 18
- 239000002002 slurry Substances 0.000 description 16
- 230000001580 bacterial effect Effects 0.000 description 15
- 239000000243 solution Substances 0.000 description 15
- 108010076504 Protein Sorting Signals Proteins 0.000 description 14
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 14
- 102000035195 Peptidases Human genes 0.000 description 13
- 235000013339 cereals Nutrition 0.000 description 13
- 229940025131 amylases Drugs 0.000 description 12
- 238000003556 assay Methods 0.000 description 12
- 241000228212 Aspergillus Species 0.000 description 11
- 238000006243 chemical reaction Methods 0.000 description 11
- 238000011534 incubation Methods 0.000 description 11
- 241000894007 species Species 0.000 description 11
- 235000000346 sugar Nutrition 0.000 description 11
- 108050008938 Glucoamylases Proteins 0.000 description 10
- 239000006227 byproduct Substances 0.000 description 10
- 239000013604 expression vector Substances 0.000 description 10
- 241000196324 Embryophyta Species 0.000 description 9
- 230000007062 hydrolysis Effects 0.000 description 9
- 238000006460 hydrolysis reaction Methods 0.000 description 9
- 229920000945 Amylopectin Polymers 0.000 description 8
- 241000193830 Bacillus <bacterium> Species 0.000 description 8
- 229920002245 Dextrose equivalent Polymers 0.000 description 8
- 241000499912 Trichoderma reesei Species 0.000 description 8
- 239000000835 fiber Substances 0.000 description 8
- 239000000523 sample Substances 0.000 description 8
- 150000008163 sugars Chemical class 0.000 description 8
- 238000013518 transcription Methods 0.000 description 8
- 230000035897 transcription Effects 0.000 description 8
- 230000009466 transformation Effects 0.000 description 8
- 241000228245 Aspergillus niger Species 0.000 description 7
- 240000006439 Aspergillus oryzae Species 0.000 description 7
- 241000233866 Fungi Species 0.000 description 7
- 230000008901 benefit Effects 0.000 description 7
- 239000012620 biological material Substances 0.000 description 7
- 230000000717 retained effect Effects 0.000 description 7
- 241001465754 Metazoa Species 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 241000223259 Trichoderma Species 0.000 description 6
- 125000000539 amino acid group Chemical group 0.000 description 6
- 235000013405 beer Nutrition 0.000 description 6
- 239000000872 buffer Substances 0.000 description 6
- 238000000926 separation method Methods 0.000 description 6
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 5
- 238000007792 addition Methods 0.000 description 5
- 235000014633 carbohydrates Nutrition 0.000 description 5
- 238000005119 centrifugation Methods 0.000 description 5
- 230000002255 enzymatic effect Effects 0.000 description 5
- 239000002609 medium Substances 0.000 description 5
- 230000000813 microbial effect Effects 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- 229920001282 polysaccharide Polymers 0.000 description 5
- 239000005017 polysaccharide Substances 0.000 description 5
- 239000001632 sodium acetate Substances 0.000 description 5
- 235000017281 sodium acetate Nutrition 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 4
- 229920000856 Amylose Polymers 0.000 description 4
- 235000002247 Aspergillus oryzae Nutrition 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 4
- 240000007594 Oryza sativa Species 0.000 description 4
- 235000007164 Oryza sativa Nutrition 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 241000209140 Triticum Species 0.000 description 4
- 238000002835 absorbance Methods 0.000 description 4
- 235000013361 beverage Nutrition 0.000 description 4
- 210000000349 chromosome Anatomy 0.000 description 4
- 210000004748 cultured cell Anatomy 0.000 description 4
- 230000000593 degrading effect Effects 0.000 description 4
- 210000002472 endoplasmic reticulum Anatomy 0.000 description 4
- 238000009396 hybridization Methods 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 239000003550 marker Substances 0.000 description 4
- 235000015097 nutrients Nutrition 0.000 description 4
- 239000003921 oil Substances 0.000 description 4
- 239000013612 plasmid Substances 0.000 description 4
- 239000002243 precursor Substances 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 238000000746 purification Methods 0.000 description 4
- 235000009566 rice Nutrition 0.000 description 4
- 239000007974 sodium acetate buffer Substances 0.000 description 4
- 230000007928 solubilization Effects 0.000 description 4
- 238000005063 solubilization Methods 0.000 description 4
- 239000012224 working solution Substances 0.000 description 4
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 3
- 241000194108 Bacillus licheniformis Species 0.000 description 3
- 235000014469 Bacillus subtilis Nutrition 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 3
- 229920002261 Corn starch Polymers 0.000 description 3
- 229920001353 Dextrin Polymers 0.000 description 3
- 239000004375 Dextrin Substances 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 239000007995 HEPES buffer Substances 0.000 description 3
- 102100026367 Pancreatic alpha-amylase Human genes 0.000 description 3
- 241000209056 Secale Species 0.000 description 3
- 241000187747 Streptomyces Species 0.000 description 3
- 108700005078 Synthetic Genes Proteins 0.000 description 3
- 229960005069 calcium Drugs 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 235000011089 carbon dioxide Nutrition 0.000 description 3
- 238000003776 cleavage reaction Methods 0.000 description 3
- 230000000295 complement effect Effects 0.000 description 3
- 239000008120 corn starch Substances 0.000 description 3
- 238000006731 degradation reaction Methods 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 150000004676 glycans Chemical class 0.000 description 3
- 230000013595 glycosylation Effects 0.000 description 3
- 238000006206 glycosylation reaction Methods 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 230000010354 integration Effects 0.000 description 3
- 239000011159 matrix material Substances 0.000 description 3
- 239000002207 metabolite Substances 0.000 description 3
- 238000002703 mutagenesis Methods 0.000 description 3
- 231100000350 mutagenesis Toxicity 0.000 description 3
- 210000001938 protoplast Anatomy 0.000 description 3
- 230000007017 scission Effects 0.000 description 3
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 239000011550 stock solution Substances 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 238000001890 transfection Methods 0.000 description 3
- 238000013519 translation Methods 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 238000001238 wet grinding Methods 0.000 description 3
- 235000020985 whole grains Nutrition 0.000 description 3
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 2
- ZMZGIVVRBMFZSG-UHFFFAOYSA-N 4-hydroxybenzohydrazide Chemical compound NNC(=O)C1=CC=C(O)C=C1 ZMZGIVVRBMFZSG-UHFFFAOYSA-N 0.000 description 2
- 241000351920 Aspergillus nidulans Species 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 244000063299 Bacillus subtilis Species 0.000 description 2
- 101710130006 Beta-glucanase Proteins 0.000 description 2
- 108020004705 Codon Proteins 0.000 description 2
- 241000195493 Cryptophyta Species 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- 241000626621 Geobacillus Species 0.000 description 2
- 241000193385 Geobacillus stearothermophilus Species 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 241000223198 Humicola Species 0.000 description 2
- 241000235058 Komagataella pastoris Species 0.000 description 2
- 102100033448 Lysosomal alpha-glucosidase Human genes 0.000 description 2
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 2
- 241000235395 Mucor Species 0.000 description 2
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 2
- 241000235648 Pichia Species 0.000 description 2
- 241000235403 Rhizomucor miehei Species 0.000 description 2
- 241000235346 Schizosaccharomyces Species 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 241000282898 Sus scrofa Species 0.000 description 2
- 241000228341 Talaromyces Species 0.000 description 2
- 241001313536 Thermothelomyces thermophila Species 0.000 description 2
- 241001557886 Trichoderma sp. Species 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- 108010028144 alpha-Glucosidases Proteins 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 2
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 2
- 235000011130 ammonium sulphate Nutrition 0.000 description 2
- 230000003625 amylolytic effect Effects 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 239000005018 casein Substances 0.000 description 2
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 2
- 235000021240 caseins Nutrition 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 2
- 229960005091 chloramphenicol Drugs 0.000 description 2
- 239000002299 complementary DNA Substances 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- 235000013365 dairy product Nutrition 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- 229910021641 deionized water Inorganic materials 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 235000019425 dextrin Nutrition 0.000 description 2
- 238000007865 diluting Methods 0.000 description 2
- 231100000673 dose–response relationship Toxicity 0.000 description 2
- 238000009837 dry grinding Methods 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 235000019985 fermented beverage Nutrition 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 2
- 125000003147 glycosyl group Chemical group 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- 230000002779 inactivation Effects 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 230000003834 intracellular effect Effects 0.000 description 2
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 description 2
- 229920005610 lignin Polymers 0.000 description 2
- 239000007791 liquid phase Substances 0.000 description 2
- 244000144972 livestock Species 0.000 description 2
- 230000001404 mediated effect Effects 0.000 description 2
- 108020004999 messenger RNA Proteins 0.000 description 2
- 238000003801 milling Methods 0.000 description 2
- 238000002887 multiple sequence alignment Methods 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 229920001542 oligosaccharide Polymers 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 230000008488 polyadenylation Effects 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 238000006116 polymerization reaction Methods 0.000 description 2
- 229920001592 potato starch Polymers 0.000 description 2
- 244000144977 poultry Species 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 230000006798 recombination Effects 0.000 description 2
- 238000005215 recombination Methods 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000010076 replication Effects 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 238000013207 serial dilution Methods 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 235000011149 sulphuric acid Nutrition 0.000 description 2
- 239000004753 textile Substances 0.000 description 2
- 238000010361 transduction Methods 0.000 description 2
- 230000026683 transduction Effects 0.000 description 2
- 238000000108 ultra-filtration Methods 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 229940100445 wheat starch Drugs 0.000 description 2
- 101710178229 1,4-beta-D-glucan glucohydrolase Proteins 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- 238000010269 ABTS assay Methods 0.000 description 1
- 101150006240 AOX2 gene Proteins 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 108091005508 Acid proteases Proteins 0.000 description 1
- 108010021809 Alcohol dehydrogenase Proteins 0.000 description 1
- 102000007698 Alcohol dehydrogenase Human genes 0.000 description 1
- 102000016912 Aldehyde Reductase Human genes 0.000 description 1
- 108010053754 Aldehyde reductase Proteins 0.000 description 1
- 241000534414 Anotopterus nikparini Species 0.000 description 1
- 108010017640 Aspartic Acid Proteases Proteins 0.000 description 1
- 102000004580 Aspartic Acid Proteases Human genes 0.000 description 1
- 241001513093 Aspergillus awamori Species 0.000 description 1
- 241000228257 Aspergillus sp. Species 0.000 description 1
- 241000228232 Aspergillus tubingensis Species 0.000 description 1
- 241000222400 Athelia Species 0.000 description 1
- 241001112741 Bacillaceae Species 0.000 description 1
- 241000193749 Bacillus coagulans Species 0.000 description 1
- 241000193422 Bacillus lentus Species 0.000 description 1
- 108010029675 Bacillus licheniformis alpha-amylase Proteins 0.000 description 1
- 241000194107 Bacillus megaterium Species 0.000 description 1
- 241000193388 Bacillus thuringiensis Species 0.000 description 1
- 108091005658 Basic proteases Proteins 0.000 description 1
- 108010006654 Bleomycin Proteins 0.000 description 1
- 241000193764 Brevibacillus brevis Species 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- 108010008885 Cellulose 1,4-beta-Cellobiosidase Proteins 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 1
- 241000193403 Clostridium Species 0.000 description 1
- 241001509321 Clostridium thermoamylolyticum Species 0.000 description 1
- 108020004635 Complementary DNA Proteins 0.000 description 1
- 125000002353 D-glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- ZAQJHHRNXZUBTE-WUJLRWPWSA-N D-xylulose Chemical compound OC[C@@H](O)[C@H](O)C(=O)CO ZAQJHHRNXZUBTE-WUJLRWPWSA-N 0.000 description 1
- 108010058076 D-xylulose reductase Proteins 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 101100342470 Dictyostelium discoideum pkbA gene Proteins 0.000 description 1
- 241000588921 Enterobacteriaceae Species 0.000 description 1
- YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 101100385973 Escherichia coli (strain K12) cycA gene Proteins 0.000 description 1
- 241000701959 Escherichia virus Lambda Species 0.000 description 1
- 241000206602 Eukaryota Species 0.000 description 1
- 108050001049 Extracellular proteins Proteins 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 241000223218 Fusarium Species 0.000 description 1
- 241000223221 Fusarium oxysporum Species 0.000 description 1
- 108010001498 Galectin 1 Proteins 0.000 description 1
- 102100021736 Galectin-1 Human genes 0.000 description 1
- 102100024637 Galectin-10 Human genes 0.000 description 1
- 101001011019 Gallus gallus Gallinacin-10 Proteins 0.000 description 1
- 101001011021 Gallus gallus Gallinacin-12 Proteins 0.000 description 1
- 101100001650 Geobacillus stearothermophilus amyM gene Proteins 0.000 description 1
- 229920001503 Glucan Polymers 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 101100295959 Halobacterium salinarum (strain ATCC 700922 / JCM 11081 / NRC-1) arcB gene Proteins 0.000 description 1
- 229920002488 Hemicellulose Polymers 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- AYRXSINWFIIFAE-SCLMCMATSA-N Isomaltose Natural products OC[C@H]1O[C@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)[C@@H](O)[C@@H](O)[C@@H]1O AYRXSINWFIIFAE-SCLMCMATSA-N 0.000 description 1
- 241000235649 Kluyveromyces Species 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 241000186604 Lactobacillus reuteri Species 0.000 description 1
- 241000186610 Lactobacillus sp. Species 0.000 description 1
- 241000178948 Lactococcus sp. Species 0.000 description 1
- 241001627205 Leuconostoc sp. Species 0.000 description 1
- 102000005431 Molecular Chaperones Human genes 0.000 description 1
- 108010006519 Molecular Chaperones Proteins 0.000 description 1
- 240000008790 Musa x paradisiaca Species 0.000 description 1
- 235000018290 Musa x paradisiaca Nutrition 0.000 description 1
- 125000001429 N-terminal alpha-amino-acid group Chemical group 0.000 description 1
- 229910021204 NaH2 PO4 Inorganic materials 0.000 description 1
- 238000000636 Northern blotting Methods 0.000 description 1
- 108091005461 Nucleic proteins Proteins 0.000 description 1
- 241000604136 Pediococcus sp. Species 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 241000235061 Pichia sp. Species 0.000 description 1
- 240000004713 Pisum sativum Species 0.000 description 1
- 235000010582 Pisum sativum Nutrition 0.000 description 1
- 241000209504 Poaceae Species 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 108010009736 Protein Hydrolysates Proteins 0.000 description 1
- 241000947836 Pseudomonadaceae Species 0.000 description 1
- 241000222644 Pycnoporus <fungus> Species 0.000 description 1
- 108010011939 Pyruvate Decarboxylase Proteins 0.000 description 1
- 238000010240 RT-PCR analysis Methods 0.000 description 1
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
- 241000235402 Rhizomucor Species 0.000 description 1
- 241000235527 Rhizopus Species 0.000 description 1
- 241000235070 Saccharomyces Species 0.000 description 1
- HIWPGCMGAMJNRG-ACCAVRKYSA-N Sophorose Natural products O([C@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HIWPGCMGAMJNRG-ACCAVRKYSA-N 0.000 description 1
- 102100026974 Sorbitol dehydrogenase Human genes 0.000 description 1
- 241000194022 Streptococcus sp. Species 0.000 description 1
- 241000187432 Streptomyces coelicolor Species 0.000 description 1
- 241001468239 Streptomyces murinus Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 241001484137 Talaromyces leycettanus Species 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- 241000193447 Thermoanaerobacter thermohydrosulfuricus Species 0.000 description 1
- 101100157012 Thermoanaerobacterium saccharolyticum (strain DSM 8691 / JW/SL-YS485) xynB gene Proteins 0.000 description 1
- 241000223257 Thermomyces Species 0.000 description 1
- 241001136490 Thermomyces dupontii Species 0.000 description 1
- 241001494489 Thielavia Species 0.000 description 1
- 235000011941 Tilia x europaea Nutrition 0.000 description 1
- 241000222354 Trametes Species 0.000 description 1
- 102000005924 Triose-Phosphate Isomerase Human genes 0.000 description 1
- 108700015934 Triose-phosphate isomerases Proteins 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 241000588901 Zymomonas Species 0.000 description 1
- 108010048241 acetamidase Proteins 0.000 description 1
- 108010045649 agarase Proteins 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- GZCGUPFRVQAUEE-SLPGGIOYSA-N aldehydo-D-glucose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O GZCGUPFRVQAUEE-SLPGGIOYSA-N 0.000 description 1
- 102000016679 alpha-Glucosidases Human genes 0.000 description 1
- 101150069003 amdS gene Proteins 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000013011 aqueous formulation Substances 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- 101150008194 argB gene Proteins 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- OHDRQQURAXLVGJ-HLVWOLMTSA-N azane;(2e)-3-ethyl-2-[(e)-(3-ethyl-6-sulfo-1,3-benzothiazol-2-ylidene)hydrazinylidene]-1,3-benzothiazole-6-sulfonic acid Chemical compound [NH4+].[NH4+].S/1C2=CC(S([O-])(=O)=O)=CC=C2N(CC)C\1=N/N=C1/SC2=CC(S([O-])(=O)=O)=CC=C2N1CC OHDRQQURAXLVGJ-HLVWOLMTSA-N 0.000 description 1
- 229940054340 bacillus coagulans Drugs 0.000 description 1
- 229940097012 bacillus thuringiensis Drugs 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 238000010923 batch production Methods 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- HIWPGCMGAMJNRG-UHFFFAOYSA-N beta-sophorose Natural products OC1C(O)C(CO)OC(O)C1OC1C(O)C(O)C(O)C(CO)O1 HIWPGCMGAMJNRG-UHFFFAOYSA-N 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229960001561 bleomycin Drugs 0.000 description 1
- OYVAGSVQBOHSSS-UAPAGMARSA-O bleomycin A2 Chemical compound N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC=C(N=1)C=1SC=C(N=1)C(=O)NCCC[S+](C)C)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1N=CNC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C OYVAGSVQBOHSSS-UAPAGMARSA-O 0.000 description 1
- 210000004899 c-terminal region Anatomy 0.000 description 1
- 238000010804 cDNA synthesis Methods 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 239000013592 cell lysate Substances 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 238000007398 colorimetric assay Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 239000012468 concentrated sample Substances 0.000 description 1
- 238000010924 continuous production Methods 0.000 description 1
- 210000000172 cytosol Anatomy 0.000 description 1
- 101150005799 dagA gene Proteins 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 125000000422 delta-lactone group Chemical group 0.000 description 1
- 238000009990 desizing Methods 0.000 description 1
- 235000013681 dietary sucrose Nutrition 0.000 description 1
- 235000019621 digestibility Nutrition 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 239000013024 dilution buffer Substances 0.000 description 1
- ORXJMBXYSGGCHG-UHFFFAOYSA-N dimethyl 2-methoxypropanedioate Chemical compound COC(=O)C(OC)C(=O)OC ORXJMBXYSGGCHG-UHFFFAOYSA-N 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 238000011143 downstream manufacturing Methods 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 101150003727 egl2 gene Proteins 0.000 description 1
- 238000004520 electroporation Methods 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- 210000001163 endosome Anatomy 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 230000007071 enzymatic hydrolysis Effects 0.000 description 1
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 102000035175 foldases Human genes 0.000 description 1
- 108091005749 foldases Proteins 0.000 description 1
- 239000000446 fuel Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 238000012224 gene deletion Methods 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 108010061330 glucan 1,4-alpha-maltohydrolase Proteins 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 235000019534 high fructose corn syrup Nutrition 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 239000000413 hydrolysate Substances 0.000 description 1
- 238000007901 in situ hybridization Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- DLRVVLDZNNYCBX-RTPHMHGBSA-N isomaltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-RTPHMHGBSA-N 0.000 description 1
- 108010032581 isopullulanase Proteins 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
- 229940001882 lactobacillus reuteri Drugs 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 239000004571 lime Substances 0.000 description 1
- 238000012417 linear regression Methods 0.000 description 1
- 238000001638 lipofection Methods 0.000 description 1
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 1
- 101150052479 lpxP gene Proteins 0.000 description 1
- 101150039489 lysZ gene Proteins 0.000 description 1
- 235000018977 lysine Nutrition 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 239000012092 media component Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 238000001471 micro-filtration Methods 0.000 description 1
- 238000000520 microinjection Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 101150095344 niaD gene Proteins 0.000 description 1
- 239000002777 nucleoside Substances 0.000 description 1
- 150000003833 nucleoside derivatives Chemical class 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 150000002972 pentoses Chemical class 0.000 description 1
- 210000002824 peroxisome Anatomy 0.000 description 1
- 238000002823 phage display Methods 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 230000001323 posttranslational effect Effects 0.000 description 1
- 235000012015 potatoes Nutrition 0.000 description 1
- 238000011533 pre-incubation Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 238000001273 protein sequence alignment Methods 0.000 description 1
- 239000012521 purified sample Substances 0.000 description 1
- 239000012429 reaction media Substances 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229920002477 rna polymer Polymers 0.000 description 1
- 108010038196 saccharide-binding proteins Proteins 0.000 description 1
- 230000001523 saccharolytic effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 210000004739 secretory vesicle Anatomy 0.000 description 1
- 239000013605 shuttle vector Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 239000002910 solid waste Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- PZDOWFGHCNHPQD-VNNZMYODSA-N sophorose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](C=O)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O PZDOWFGHCNHPQD-VNNZMYODSA-N 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 230000002103 transcriptional effect Effects 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 230000005945 translocation Effects 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 241001515965 unidentified phage Species 0.000 description 1
- 210000003934 vacuole Anatomy 0.000 description 1
- 101150110790 xylB gene Proteins 0.000 description 1
- 150000008496 α-D-glucosides Chemical class 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
- C12N9/2405—Glucanases
- C12N9/2408—Glucanases acting on alpha -1,4-glucosidic bonds
- C12N9/2411—Amylases
- C12N9/2414—Alpha-amylase (3.2.1.1.)
- C12N9/2417—Alpha-amylase (3.2.1.1.) from microbiological source
- C12N9/242—Fungal source
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/38—Products with no well-defined composition, e.g. natural products
- C11D3/386—Preparations containing enzymes, e.g. protease or amylase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01001—Alpha-amylase (3.2.1.1)
Definitions
- the present disclosure relates to polypeptides having alpha-amylase activity and compositions comprising such polypeptides.
- the present disclosure further relates to polynucleotides encoding such polypeptides, engineered nucleic acid constructs, vectors and host cells comprising genes encoding such polypeptides, which may also enable the production of such polypeptides.
- the disclosure relates to methods of recombinantly producing such polypeptides or such compositions, as well as methods of using or applying the polypeptides or compositions thus produced in industrial settings, for example, for starch treatment, such as liquefaction, saccharification and/or fermentation, or beverage preparation.
- Starch consists of a mixture of amylose (15-30% w/w) and amyiopectin (70-85% w/w).
- Amylose consists of linear chains of alpha- 1 ,4-linked glucose units having a molecular weight (MW) from about 60,000 to about 800,000
- MW molecular weight
- Amyiopectin is a branched polymer containing alpha- 1,6 branch points every 24-30 glucose units; its MW may be as high as 100 million.
- Alpha-amylases hydrolyze starch, glycogen, and related polysaccharides by cleaving internal alpha-1 , 4-glucosidic bonds at random.
- Alpha-amylase enzymes have been used for a variety of different purposes, such as, starch liquefaction, saccharification, fermentation, brewing, baking, textile desizing, textile washing, starch modification in the paper and pulp industry and digestability increasing in animal feed.
- alpha-amylases suitable for these industrial processes can be diverse. There is as such always a need in the art for alternative alpha- amylases with improved or different properties such as pH optimum, temperature optimum, substrate specificities, and/or thermostability.
- a polypeptide having alpha-amylase activity selected from the group consisting of:
- polypeptide comprising an amino acid sequence having preferably at least one amino acid sequence having preferably at least one amino acid sequence having preferably at least one amino acid sequence having preferably at least one amino acid sequence having preferably at least one amino acid sequence having preferably at least one amino acid sequence having preferably at least one amino acid sequence having preferably at least one amino acid sequence having preferably at least one amino acid sequence having preferably at least one amino acid sequence having preferably at least one amino acid sequence having preferably at least
- polypeptide comprising an amino acid sequence having preferably at least one amino acid sequence having preferably at least one amino acid sequence having preferably at least one amino acid sequence having preferably at least one amino acid sequence having preferably at least one amino acid sequence having preferably at least one amino acid sequence having preferably at least one amino acid sequence having preferably at least one amino acid sequence having preferably at least one amino acid sequence having preferably at least one amino acid sequence having preferably at least one amino acid sequence having preferably at least
- polypeptide encoded by a polynucleotide comprising a nucleotide sequence having preferably at least 90% identity to the polypeptide coding sequence of SEQ ID NO: 3;
- a polynucleotide comprising a nucleotide sequence that encodes the polypeptide of paragraph 1.
- a vector comprising the polynucleotide of paragraph 2 operably linked to one or more control sequences that control the production of the polypeptide in an expression host.
- a recombinant host cell comprising the polynucleotide of paragraph 2.
- the host cell of paragraph 4 which is an ethanologenic microorganisms.
- the host cell of paragraphs 4 or 5 which further expresses and secretes one or more additional enzymes selected from the group comprising a protease, hemicellulase, cellulase, peroxidase, lipolytic enzyme, xylanase, lipase, phospholipase, esterase, perhydrolase, cutinase, pectinase, pectate lyase, mannanase, keratinase, reductase, oxidase, phenoloxidase, lipoxygenase, iigninase, glucoamylase, pullulanase, phytase, tannase, pentosanase, malanase, beta-glucanase, arahinosidase, hyaluronidase, chondroitmase, laccase, transferase, or a combination thereof
- composition comprising the polypeptide of paragraph 1.
- composition of paragraph 7 further comprising a protease, hemicellulase, cellulase, peroxidase, lipolytic enzyme, xylanase, lipase, phospholipase, esterase, perhydrolase, cutinase, pectinase, pectate lyase, mannanase, keratinase, reductase, oxidase, phenoloxidase, lipoxygenase, Iigninase, glucoamylase, pullulanase, phytase, tannase, pentosanase, malanase, beta-glucanase, arahinosidase, hyaluronidase, chondroitmase, laccase, transferase, or a combination thereof.
- a protease hemicellulase, cellulase, peroxidase
- a method of producing a polypeptide having alpha-amylase activity comprising:
- a method for saccharifying a starch substrate comprising
- the high glucose syrup comprises an amount of glucose selected from the list consisting of at least 95.5% glucose, at least 95.6% glucose, at least 95.7% glucose, at least 95.8% glucose, at least 95.9% glucose, at least 96% glucose, at least 96.1 % glucose, at least 96.2% glucose, at least 96.3% glucose, at least 96.4% glucose, at least 96.5% glucose and at least 97% glucose.
- saccharifying and fermenting are carried out as a simultaneous saccharification and fermentation (SSF) process.
- SSF simultaneous saccharification and fermentation
- the end product is a biochemical selected from the group consisting of an amino acid, an organic acid, citric acid, lactic acid, succinic acid, monosodium glutamate, gluconic acid, sodium gluconate, calcium gluconate, potassium gluconate, giucono delta-lactone, sodium erythorbate, omega 3 fatty acid, butanol, lysine, itaeonic acid, 1 ,3-propanediol, biodiesel, and isoprene.
- a biochemical selected from the group consisting of an amino acid, an organic acid, citric acid, lactic acid, succinic acid, monosodium glutamate, gluconic acid, sodium gluconate, calcium gluconate, potassium gluconate, giucono delta-lactone, sodium erythorbate, omega 3 fatty acid, butanol, lysine, itaeonic acid, 1 ,3-propanediol, biodiesel
- starch substrate is about, 5% to 99%, 15% to 50% or 40-99% dry solid (DS).
- starch substrate is selected from wheat, barley, com, rye, rice, sorghum, bran, cassava, mho, millet, potato, sweet potato, tapioca, and any combination thereof.
- starch substrate comprises liquefied starch, gelatinized starch, or granular starch.
- a method for saccharify ing and fermenting a starch substrate to produce an end product comprising
- fermenting are carried out as a simultaneous saccharification and fermentation (SSF) process.
- SSF simultaneous saccharification and fermentation
- the end product is a biochemical selected from the group consisting of an amino acid, an organic acid, citric acid, lactic acid, succinic acid, monosodium glutamate, gluconic acid, sodium gluconate, calcium gluconate, potassium gluconate, glucono delta-lactone, sodium erythorbate, omega 3 fatty' acid, butanol, lysine, itaconic acid, 1 , 3-propanediol, biodiesel, and isoprene.
- a biochemical selected from the group consisting of an amino acid, an organic acid, citric acid, lactic acid, succinic acid, monosodium glutamate, gluconic acid, sodium gluconate, calcium gluconate, potassium gluconate, glucono delta-lactone, sodium erythorbate, omega 3 fatty' acid, butanol, lysine, itaconic acid, 1 , 3-propanediol, biodiesel
- Figure 1 depicts the pZKY258 expression vector harboring the synthetic gene of Asp Amy 14 alpha amylase
- Figure 2 shows the dose response curves of starch solubilization activity for AspAmy 14 and AcAA alpha amylases.
- Panel A shows results at pH 3 7 and Panel B show results at pH 4.5
- Figure 3 shows a MUSCLE multiple protein sequence alignment for AspAmy 14 and various homologous fungal alpha amylase described in Example 11.
- polypeptides from Aspergillus having alpha-amylase activity and compositions comprising such polypeptides.
- the present disclosure further relates to polynucleotides encoding such polypeptides, engineered nucleic acid constructs, vectors and host cells comprising genes encoding such polypeptides, which may also enable the production of such polypeptides.
- the disclosure relates to methods of recombinantly producing such polypeptides or such compositions, as well as methods of using or applying the polypeptides or compositions thus produced in industrial settings, for example, for starch liquefaction, saccharification, fermentation and food or beverage preparation.
- PAHBAH p-hydroxy benzoic acid hydrazide
- ppm parts per million e.g., pg protein per gram dry solid
- TrGA Trichoderma reesei glucoamylase
- amylase or“amylolytic enzyme” refer to an enzyme that is, among other things, capable of catalyzing the degradation of starch.
- Alpha-amylases are hydrolases that cleave the alpha-D-(l- 4) O-glycosidic linkages in starch.
- alpha-amylases (EC 3.2.1.1; alpha-D-( 1 -®4)-glucan glucanohydrolase) are defined as endo-acting enzymes cleaving alpha-D-(l 4) O-glycosidic linkages within the starch molecule in a random fashion yielding polysaccharides containing three or more (l-4)-alpha-linked D-glucose units.
- exo-acting amylolytic enzymes such as beta-amylases (EC 3.2.1.2; alpha-D- (]— ->4)-giucan maltohydrolase) and some product-specific amylases like maltogemc alpha- amylase (EC 3.2.1.133) cleave the polysaccharide molecule from the non-reducing end of the substrate.
- Beta-amylases alpha-glucosidases (EC 3.2.1.20; alpha-D-glucoside glucohydrolase), glucoamylase (EC 3.2.1.3; a!pha-D-(l- 4) ⁇ glucan glucohydrolase), and product-specific amylases like the maltotetraosidases (EC 3.2.1.60) and the maltohexaosidases (EC 3.2.1.98) can produce malto-oligosaccharides of a specific length or enriched syrups of specifi c m al tool! gos acch ari des .
- starch refers to any material comprised of the complex polysaccharide carbohydrates of plants, comprised of amylose and amylopectin with the formula (C6H10O5)x, wherein X can be any number.
- the term includes plant-based materials such as grains, cereal, grasses, tubers and roots, and more specifically materials obtained from wheat, barley, com, rye, rice, sorghum, brans, cassava, millet, miio, potato, sweet potato, and tapioca.
- starch includes granular starch.
- granular starch refers to raw, i.e., uncooked starch, e.g., starch that has not been subject to ge!atinization or that has been subjected to temperatures at or below' the gelatinization temperature of the starch.
- the terms,“wild-type,”“parental,” or“reference,” with respect to a polypeptide refer to a naturally-occurring polypeptide that does not include a man-made substitution, insertion, or deletion at one or more ammo acid positions.
- the terms“wild-type,”“parental,” or“reference,” with respect to a polynucleotide refer to a naturally-occurring polynucleotide that does not include a man-made nucleoside change.
- a polynucleotide encoding a wild-type, parental, or reference polypeptide is not limited to a naturally-occurring polynucleotide, and encompasses any polynucleotide encoding the wild-type, parental, or reference polypeptide.
- polypeptides which are to be secreted, are translocated into the endoplasmic reticulum (ER).
- ER endoplasmic reticulum
- hydrophobic N-terminal signal peptide which allows for co- or post-translational translocation from the cytosol to the ER lumen and typically consists of 13 to 36 mostly hydrophobic ammo acids (pre-sequence) (Ng et al., 1996; Zimmermann et al., 2011).
- pre-sequence hydrophobic ammo acids
- proteins are delivered to their final cellular location, which may be the ER, Golgi, secretory vesicles, peroxisomes, endosomes, vacuole, cell wall or the cell exterior (recently reviewed by De!ic et al., 2013).
- the folding, secretion and processing ability of the cell is different for each protein and that the N-terminal amino acids may influence cleavage of the secretion leader (Wang et ah, 2014).
- Some proteins are modified posttranslationally, for example, by cleavage from a protein precursor, and therefore may have different amino acids at their N-terminus. The exact N-terminal sequence is also liable to exhibit a distinctive pattern depending on the experimental conditions.
- the term“variant,” with respect to a polypeptide, refers to a polypeptide that differs from a specified wild-type, parental, or reference polypeptide in that it includes one or more naturally-occurring or man-made substitutions, insertions, or deletions of an amino acid.
- the term“variant,” with respect to a polynucleotide refers to a polynucleotide that differs in nucleotide sequence from a specified wild-type, parental, or reference polynucleotide. The identity of the wild-type, parental, or reference polypeptide or polynucleotide will be apparent from context.
- “activity” refers to alpha-amylase activity', which can he measured as described, herein.
- recombinant when used in reference to a subject cell, nucleic acid, protein or vector, indicates that the subject has been modified from its native state.
- recombinant cells express genes that are not found within the native (non- recombinant) form of the cell, or express native genes at different levels or under different conditions than found in nature.
- Recombinant nucleic acids differ from a native sequence by one or more nucleotides and/or are operably linked to heterologous sequences, e.g , a heterologous promoter in an expression vector.
- Recombinant proteins may differ from a native sequence by one or more amino acids and/or are fused with heterologous sequences.
- a vector comprising a nucleic acid encoding an amylase is a recombinant vector.
- purified refers to material (e.g., an isolated polypeptide or polynucleotide) that is in a relatively pure state, e.g., at least about 90% pure, at least about 95% pure, at least about 98% pure, or even at least about 99% pure.
- the term“enriched” refers to material (e.g., an isolated polypeptide or polynucleotide) that is about 50% pure, at least about 60% pure, at least about 70% pure, or even at least about 70% pure.
- thermostability refers to the ability of the enzyme to retain activity after exposure to an elevated temperature.
- the thermostability' of an enzyme such as an amylase enzy me, is measured by its half-life (ti /i ) given in minutes, hours, or days, during which half the enzyme activity is lost under defined conditions.
- the half-life may be calculated by measuring residual alpha-amylase activity for example following exposure to (i.e., challenge by) an elevated temperature.
- A“pH range,” with reference to an enzyme, refers to the range of pH values under which the enzyme exhibits catalytic activity.
- the terms“pH stable” and“pH stability,” with reference to an enzyme, relate to the ability' of the enzyme to retain activity over a w de range of pH values for a predetermined period of time (e.g., 15 min., 30 min., 1 hour).
- amino acid sequence is synonymous with the terms “polypeptide,” “protein,” and“peptide,” and are used interchangeably. Where such amino acid sequences exhibit activity', they may be referred to as an“enzyme.”
- the conventional one-letter or three-letter codes for ammo acid residues are used, with amino acid sequences being presented in the standard amino-to-carboxy terminal orientation (i.e., N C).
- nucleic acid encompasses DNA, RNA, heteroduplexes, and synthetic molecules capable of encoding a polypeptide. Nucleic acids may be single stranded or double stranded, and may be chemically modified. The terms“nucleic acid” and“polynucleotide” are used interchangeably. Because the genetic code is degenerate, more than one codon may ⁇ be used to encode a particular amino acid, and the present compositions and methods encompass nucleotide sequences that encode a particular amino acid sequence. Unless otherwise indicated, nucleic acid sequences are presented in 5'-to-3' orientation.
- hybridization refers to the process by which one strand of nucleic acid forms a duplex with, i.e., base pairs with, a complementary strand, as occurs during blot hybridization techniques and PCR techniques.
- Hybridized, duplex nucleic acids are characterized by a melting temperature (T m ), where one half of the hybridized nucleic acids are unpaired with the complementary strand. Mismatched nucleotides within the duplex lower the T m .
- [QQ28] A“synthetic” molecule is produced by in vitro chemical or enzymatic synthesis rather than by an organism.
- the term“introduced” in the context of inserting a nucleic acid sequence into a cell means“transfection”,“transformation” or“transduction,” as known in the art.
- A“host strain” or“host cell” is an organism into which an expression vector, phage, virus, or other DNA construct, including a polynucleotide encoding a polypeptide of interest (e.g. , an amylase) has been introduced.
- Exemplary host strains are microorganism cells (e.g., bacteria, filamentous fungi, and yeast) capable of expressing the polypeptide of interest and/or fermenting saccharides.
- the term“host cell” includes protoplasts created from cells.
- heterologous with reference to a polynucleotide or protein refers to a polynucleotide or protein that does not naturally occur in a host cell.
- endogenous with reference to a polynucleotide or protein refers to a polynucleotide or protein that occurs naturally in the host cell.
- A“selecti ve marker” or“selectable marker” refers to a gene capable of being expressed in a host to facilitate selection of host cells carrying the gene. Examples of selectable markers include but are not limited to antimicrobials (e.g., hygromycin, bleomycin, or chloramphenicol) and/or genes that confer a metabolic advantage, such as a nutritional advantage on the host cell.
- vector refers to a polynucleotide sequence designed to introduce nucleic acids into one or more cell types.
- Vectors include cloning vectors, expression vectors, shuttle vectors, plasmids, phage particles, cassettes and the like.
- An “expression vector” refers to a DNA construct comprising a DNA sequence encoding a polypeptide of interest, which coding sequence is operably linked to a suitable control sequence capable of effecting expression of the DNA in a suitable host.
- control sequences may include a promoter to effect transcription, an optional operator sequence to control transcription, a sequence encoding suitable ribosome binding sites on the mRNA, enhancers and sequences which control termination of transcription and translation.
- operably linked means that specified components are in a relationship (including but not limited to juxtaposition) permitting them to function in an intended manner.
- a regulatory sequence is operably linked to a coding sequence such that expression of the coding sequence is under control of the regulatory sequences.
- A“signal sequence” is a sequence of amino acids attached to the N-terminal portion of a protein, which facilitates the secretion of the protein outside the cell.
- the mature form of an extracellular protein lacks the signal sequence, which is cleaved off during the secretion process.
- Biologically active refer to a sequence having a specified biological activity, such an enzymatic activity.
- specific activity refers to the number of moles of substrate that can be converted to product by an enzyme or enzyme preparation per unit time under specific conditions. Specific activity is generally expressed as units (U)/mg of protein.
- a cultured cell material comprising an amylase refers to a cell lysate or supernatant (including media) that includes an amylase as a component.
- the cell material may be from a heterologous host that is grown in culture for the purpose of producing the amylase.
- Percent sequence identity means that a particular sequence has at least a certain percentage of amino acid residues identical to those in a specified reference sequence, when aligned using the CLUSTAL W algorithm with default parameters. See Thompson et al.
- Gap extension penalty 0.05
- “Fused” polypeptide sequences are connected, i.e., operably linked, via a peptide bond between two subject polypeptide sequences.
- the term“degree of polymerization” refers to the number (n) of anhydro- glucopyranose units in a given saccharide.
- DPI the monosaccharides glucose and fructose.
- DP2 the disaccharides maltose and sucrose.
- DE or“dextrose equivalent,” is defined as the percentage of reducing sugar, i.e. , D- glucose, as a fraction of total carbohydrate in a syrup.
- dry solids content refers to the total solids of a slurry in a dry weight percent basis.
- slurry refers to an aqueous mixture containing insoluble solids.
- SSF saccharification and fermentation
- An “ethanologenic microorganism” refers to a microorganism with the ability to convert a sugar or other carbohydrates to ethanol
- biochemicals refers to a metabolite of a microorganism, such as citric acid, lactic acid, succinic acid, monosodium glutamate, gluconic acid, sodium gluconate, calcium gluconate, potassium gluconate, glucono delta-lactone, sodium erythorbate, omega 3 fatty acid, butanol, iso-butanol, an amino acid, lysine, itaconic acid, other organic acids, 1 ,3- propanediol, vitamins, or isoprene or other biomaterial.
- a microorganism such as citric acid, lactic acid, succinic acid, monosodium glutamate, gluconic acid, sodium gluconate, calcium gluconate, potassium gluconate, glucono delta-lactone, sodium erythorbate, omega 3 fatty acid, butanol, iso-butanol, an amino acid, lysine, itaconic acid, other organic
- the term “fermented beverage” refers to any beverage produced by a method comprising a fermentation process, such as a microbial fermentation, e.g., a bacterial and/or fungal fermentation.
- a fermentation process such as a microbial fermentation, e.g., a bacterial and/or fungal fermentation.
- “Beer” is an example of such a fermented beverage, and the term“beer” is meant to comprise any fermented wort produced by fermentation/brewing of a starch- containing plant material. Often, beer is produced exclusively from malt or adjunct, or any combination of malt and adjunct.
- the present invention relates to polypeptides comprising an amino acid sequence having preferably at least 90%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, and even at least 99%, amino acid sequence identity to the polypeptide of SEQ ID NO: 3, and having alpha-amylase activity .
- the polypeptides of the present invention are the homologous polypeptides comprising amino acid sequences differ by ten amino acids, preferably by nine amino acids, preferably by eight amino acids, preferably by seven amino acids, preferably by six amino acids, preferably by five ammo acids, more preferably by four amino acids, even more preferably by three amino acids, most preferably by two amino acids, and even most preferably by one amino acid from the polypeptide of SEQ ID NO: 3.
- the polypeptides of the present invention are the variants of polypeptide of SEQ ID NO: 3, or a fragment thereof having alpha-amylase activity.
- the polypeptides of the present invention are the catalytic regions comprising the amino acids 22 to 499 of SEQ ID NO: 2, predicted by Clustalx htps : // www. ncbi nlm. nih . go v/pubmed/ 17846036.
- the polypeptides of the present invention are the catalytic regions and linker regions comprising the amino acids 22 to 550 of SEQ ID NO: 2, predicted by Clustalx htps://www.ncbi . nlm. nih. gov/p ubmed/l 7846036.
- the present alpha-amylases comprise conservative substitution of one or several amino acid residues relative to the amino acid sequence of SEQ ID NO: 3.
- Exemplary conservative amino acid substitutions are listed in the Table I. Some conservative mutations can be produced by genetic manipulation, while others are produced by introducing synthetic amino acids into a polypeptide by other means.
- the present alpha-amylase comprises a deletion, substitution, insertion, or addition of one or a few amino acid residues relative to the amino acid sequence of SEQ ID NO: 3.
- the present alpha-amylases are derived from the amino acid sequence of SEQ ID NO: 3 by conservative substitution of one or several ammo acid residues.
- the present alpha-amylases are derived from the amino acid sequence of SEQ ID NO: 3 by deletion, substitution, insertion, or addition of one or a few ammo acid residues relative to the amino acid sequence of SEQ ID NO: 3.
- the expression "one or a few amino acid residues" refers to 10 or less, i.e., 1, 2, 3, 4, 5, 6, 7, 8, 9, or 10, amino acid residues.
- the present invention also relates to carbohydrate binding domain variants of SEQ ID NO: 3 comprising a substitution, deletion, and/or insertion at one or more (e.g., several) positions.
- the present amylases may be "precursor,” “immature,” or “full-length,” in which case they include a signal sequence, or “mature,” in which case they lack a signal sequence. Mature forms of the polypeptides are generally the most useful. Unless otherwise noted, the ammo acid residue numbering used herein refers to the mature forms of the respecti v e amylase polypeptides. The present amylase polypeptides may also be truncated to remove the N or C- termini, so long as the resulting polypeptides retain amylase activity .
- ammo acid changes are of such a nature that the physico chemical properties of the polypeptides are altered.
- amino acid changes may improve the thermal stability of the polypeptide, alter the substrate specificity, change the pH optimum, and the like.
- Mutagenesis/shuffling methods can be combined with high-throughput, automated screening methods to detect activity of cloned, mutagenized polypeptides expressed by host ceils (Ness et al., 1999, Nature Biotechnology 17: 893-896). Mutagemzed DNA molecules that encode active polypeptides can be recovered from the host cells and rapidly sequenced using standard methods in the art. These methods allow the rapid determination of the importance of individual ammo acid residues a polypeptide of interest, and can be applied to polypeptides of unknown structure.
- the present amylase may he a "chimeric" or “hybrid” polypeptide, in that it includes at least a portion from a first amylase, and at least a portion from a second amylase, g!ucoamy!ase, beta-amylase, alpha-giucosidase or other starch degrading enzymes, or even other glycosyl hydrolases, such as, without limitation, cellu!ases, hemicellu!ases, etc. (including such chimeric amylases that have recently been “rediscovered” as domain-swap amylases).
- the present amylases may further include heterologous signal sequence, an epitope to allow tracking or purification, or the like. Exemplary heterologous signal sequences are from B. licheniformis amylase (LAT), B. subtiiis (AmyE or AprE), and Streptomyces CelA.
- the present alpha-amylases can be produced in host cells, for example, by secretion or intracellular expression.
- a cultured cell material e.g. , a whole-cell broth
- an alpha- amylase can be obtained following secretion of the alpha-amylase into the cell medium.
- the alpha-amylase can be isolated from the host cells, or even isolated from the cell broth, depending on the desired purity' of the final alpha-amylase.
- a gene encoding an alpha- amylase can be cloned and expressed according to methods well known in the art.
- Suitable host cells include bacterial, fungal (including yeast and filamentous fungi), and plant cells (including algae).
- host cells include Aspergillus niger, Aspergillus oryzae, Trichoderma reesi or Myceliopthora thermophila.
- Other host cells include bacterial cells, e.g. , Bacillus subtiiis or B. licheniformis, as well as Streptomyces.
- the host may express one or more accessory' enzymes, proteins, peptides. These may benefit liquefaction, saccharification, fermentation, SSF, and downstream processes.
- the host cell may produce ethanol and other biochemicals or biomaterials in addition to enzymes used to digest the various feedstock(s). Such host cells may be useful for fermentation or simultaneous saccharification and fermentation processes to reduce or eliminate the need to add enzymes. 3.1. Vectors
- a DNA construct comprising a nucleic acid encoding alpha-amylases can be constructed to be expressed in a host cell. Because of the well-known degeneracy in the genetic code, different polynucleotides that encode an identical ammo acid sequence can be designed and made with routine skill. It is also well-known in the art to optimize codon use for a particular host cell. Nucleic acids encoding alpha-amylases can be incorporated into a vector. Vectors can be transferred to a host cell using well-known transformation techniques, such as those disclosed below.
- the vector may be any vector that can be transformed into and replicated within a host cell.
- a vector comprising a nucleic acid encoding an alpha-amylase can be transformed and replicated in a bacterial host cell.
- a vector comprising a nucleic acid encoding an alpha-amylase can also be transformed and conveniently integrated into the chromosome (in one or more copies) of a bacterial host cell, and the integration is generally considered to be an advantage, as the DNA sequence is more likely to be stably maintained in the cell.
- a representative useful vector is p2JM103BBI (Vogtentanz, Protein Expr Purif, 55:40- 52, 2007), which can be modified with routine skill and integrated into the chromosome of host cell such that they comprise other DNA fragments to improve the expression alpha-amylases of the invention.
- Host cells that serve as expression hosts can include filamentous fungi, for example.
- the Fungal Genetics Stock Center (FGSC) Catalogue of Strains lists suitable vectors for expression in fungal host cells. See FGSC, Catalogue of Strains, University of Missouri, at www. fgsc.net (last modified January 17, 2007).
- a representative useful vector is pTrexSgM (see, Published US Patent Application 20130323798) and pTTT (see, Published US Patent Application 20110020899), which can be inserted into genome of host.
- the vectors pTrexSgM and pTTT can both be modified with routine skill such that they comprise and express a polynucleoti de encoding an alpha-amylase polypeptide of the inventi on.
- a nucleic acid encoding an alpha-amylase can be operably linked to a suitable promoter, which allows transcription in the host ceil.
- the promoter may be any DNA sequence that shows transcriptional activity in the host cell of choice and may be derived from genes encoding proteins either homologous or heterologous to the host cell.
- Exemplary promoters for directing the transcription of the DNA sequence encoding an alpha-amylase, especially in a bacterial host are the promoters derived from the lac operon of E.
- coli the Streptomyces coelicolor agarase gene dagA or celA, the Bacillus licheniformis alpha-amylase gene (arnyL), the Bacillus stear other mophilus maltogenic amylase gene (amyM), the Bacillus amyloUquefaciem alpha-amylase gene (amyQ), the Bacillus subtilis xylA and xylB genes etc.
- useful promoters are those derived from the gene encoding Aspergillus oryzae TAKA amylase, Khizomucor miehei aspartic proteinase, Aspergillus mger neutral alpha-amylase, A.
- a suitable promoter can be selected, for example, from a bacteriophage promoter including a T7 promoter and a phage lambda promoter.
- suitable promoters for the expression in a yeast species include but are not limited to the Gal 1 and Gal 10 promoters of Saccharomyces cerevisiae and the Pichia pastoris AOXl or AOX2 promoters.
- suitable promoter for the expression m filamentous fungi include but are not limited to cbhl, an endogenous, inducible promoter from 71 reesei. See Liu et al. (2008)“Improved heterologous gene expression in Trichoderma reesei by cellobiohydrolase I gene (cbhl) promoter optimization,” Acta Biochim. Biophys. Sin (Shanghai) 40(2): 158-65.
- the coding sequence can be operably linked to a signal sequence.
- the DNA encoding the signal sequence may be the DNA sequence naturally associated with the amylase gene to he expressed or from a different genus or species.
- a DNA construct or vector comprising a signal sequence and a promoter sequence can be introduced into a fungal host cell and can be derived from the same source.
- the signal sequence is the cbhl signal sequence that is operably linked to a cbhl promoter.
- An expression vector may also comprise a suitable transcription terminator and, in eukaryotes, polyadenylation sequences operably linked to the DNA sequence encoding an alpha-amylase. Termination and polyadenylation sequences may suitably be derived from the same sources as the promoter.
- the vector may further comprise a DNA sequence enabling the vector to replicate m the host cell.
- a DNA sequence enabling the vector to replicate m the host cell. Examples of such sequences are the origins of replication of plasmids pUC19, pAC. ' YC ! 77. pUBl lO, pf.194. pAMBl , and pU702.
- the vector may also comprise a selectable marker, e.g., a product of a gene complements a defect in the isolated host cell, such as the dal genes from B. subtilis or B. lichemformis, or a gene that confers antibiotic resistance such as, e.g. , ampicillin, kanamycin, chloramphenicol or tetracycline resistance.
- a selectable marker e.g., a product of a gene complements a defect in the isolated host cell, such as the dal genes from B. subtilis or B. lichemformis, or a gene that confers antibiotic resistance such as, e.g. , ampicillin, kanamycin, chloramphenicol or tetracycline resistance.
- the vector may comprise Aspergillus selection markers such as amdS , argB, niaD and xxsC, a marker giving rise to hygrornycin resistance, or the selection may be accomplished by co-transformation,
- Intracellular expression may be advantageous in some respects, e.g., when using certain bacteria or fungi as host cells to produce large amounts of amylase for subsequent enrichment or purification.
- Extracellular secretion of amylase into the culture medium can also be used to make a cultured cell material comprising the isolated amylase.
- An isolated cell is advantageously used as a host cell in the recombinant production of an amylase.
- the cell may be transformed with the DNA construct encoding the enzyme, conveniently by integrating the DNA construct (in one or more copies) in the host chromosome. This integration is generally considered to be an advantage, as the DNA sequence is more likely to be stably maintained in the cell. Integration of the DNA constructs into the host chromosome may be performed according to conventional methods, e.g., by homologous or heterologous recombination. Alternatively, the cell may be transformed with an expression vector as described above in connection with the different types of host cells.
- suitable bacterial host organisms are Gram positive bacterial species such as Bacillaceae including Bacillus subtilis, Bacillus licheniformis, Bacillus lentus, Bacillus brevis , Geobacillus (formerly Bacillus) stearothermophilus, Bacillus alkalophilus, Bacillus amyloUquefaciem, Bacillus coagulans, Bacillus laulus, Bacillus megaterium, and Bacillus thuringiensis; Streptomyces species such as Streptomyces murinus : lactic acid bacterial species including Lactococcus sp. such as Laciococcus lacks; Lactobacillus sp.
- Bacillaceae including Bacillus subtilis, Bacillus licheniformis, Bacillus lentus, Bacillus brevis , Geobacillus (formerly Bacillus) stearothermophilus, Bacillus alkalophilus, Bacillus amyloUquefaciem, Bac
- strains of a Gram negative bacterial species belonging to Enterobacteriaceae including E. edit, or to Pseudomonadaceae can be selected as the host organism.
- a suitable yeast host organism can be selected from the biotechnologically relevant yeasts species such as but not limited to yeast species such as Pichia sp., Hansenula sp., or Kluyveromyces, Yarrowinia, Schizosaccharomyces species or a species of Saccharomyces, including Saccharomyces cerevisiae or a species belonging to Schizosaccharomyces such as, for example, S. pombe species.
- a strain of the methylotrophic yeast species, Pichia pastoris can be used as the host organism.
- the host organism can be a Hansenula species.
- Suitable host organisms among filamentous fungi include species of Aspergillus, e.g., Aspergillus niger , Aspergillus oryzae, Aspergillus tubigensis, Aspergillus aw amor i , or Aspergillus nidulans.
- a suitable procedure for transformation of Aspergillus host cells includes, for example, that described in EP 238023.
- strains of a Fusarium species e.g., Fusarium oxysporum or of a Rhizomucor species such as Rhizomucor miehei can be used as the host organism.
- Trichoderma sp. can be used as a host.
- a suitable procedure for transformation of Trichoderma host cells includes, for example, that described by Penttila et al. [Gene 61(1987) 155-164]
- An amylase expressed by a fungal host cell can be glycosylated, /. ⁇ ?., will comprise a glycosyl moiety.
- the glycosylation pattern can be the same or different as present in the wild-type amylase.
- the type and/or degree of glycosylation may impart changes in enzymatic and/or biochemical properties.
- Gene inactivation may be accomplished by complete or partial deletion, by insertional inactivation or by any other means that renders a gene nonfunctional for its intended purpose, such that the gene is prevented from expression of a functional protein.
- Any gene from a Trichoderma sp. or other filamentous fungal host that has been cloned can be deleted, for example, cbhl, chh2, egll, and egl2 genes.
- Gene deletion may be accomplished by inserting a form of the desired gene to be inactivated into a plasmid by methods known in the art.
- the suitable host cell may be the ethanologenic microbial cell, which may express one or more of the amylase homologs described herein, and/or other Bacillus amylases (including from B. hcheniformis , B. stearothermophilus , B. substihs, and other Bacillus species), and/or amylases from other sources. These may further express a homologous or heterologous starch degrading enzymes, such as glucoamylase, i.e., a glucoamylase that is not the same species as the host cell. Additionally, the host may express one or more accessory enzymes, proteins, and/or peptides.
- the host cell may produce ethanol and other bioehemicals or biomaterials in addition to enzymes used to digest the various feedstock(s). Such host cells may be useful for fermentation or simultaneous saccharification and fermentation processes to reduce or eliminate the need to add enzymes.
- Introduction of a DNA construct or vector into a host cell includes techniques such as transformation; electroporation; nuclear microinjection; transduction; transfection, e.g., lipofection mediated and DEAE-Dextrin mediated transfection; incubation with calcium phosphate DNA precipitate; high velocity bombardment with DNA-coated microprojectiles; and protoplast fusion.
- General transformation techniques are known in the art. See e.g., Sambrook et al. (2001 ), supra.
- the expression of heterologous protein in Trichoderma is described, for example, in U.S. Patent No. 6,022,725. Reference is also made to Cao et al. (2000) Science 9:991-1001 for transformation of Aspergillus strains.
- a method of producing an amylase may comprise cultivating a host cell as described above under conditions conducive to the production of the enzyme and recovering the enzyme from the cells and/or culture medium.
- the medium used to cultivate the cells may be any conventional medium suitable for growing the host cell and obtaining expression of a alpha-amylase polypeptide. Suitable media and media components are available from commercial suppliers or may be prepared according to published recipes (e.g., as described in catalogues of the American Type Culture Collection).
- fungal cells are grown under batch or continuous fermentation conditions.
- assays can measure the expressed protein, corresponding mRNA, or alpha- amylase activity.
- suitable assays include Northern blotting, reverse transcriptase polymerase chain reaction, and in situ hybridization, using an appropriately labeled hybridizing probe.
- Suitable assays also include measuring amylase activity in a sample, for example, by assays directly measuring reducing sugars such as glucose in the culture media. For example, glucose concentration may be determined using glucose reagent kit No. 15-UV (Sigma Chemical Co.) or an instrument, such as Techmcon autoanalyzer.
- Alpha- Amylase activity also may be measured by any known method, such as the PAHBAH or ABTS assays, described below'.
- alpha-amylases are useful for a variety of industrial applications.
- alpha-amylases are useful in a starch degradation processes, particularly in liquefaction of gelatinized starch, simultaneous liquefaction and saccharification, saccharification, fermentation, and/or simultaneous saccharification and fermentation (SSF).
- SSF simultaneous saccharification and fermentation
- the starch conversion process may be a precursor to, or simultaneous with, a fermentation process designed to produce alcohol for fuel or drinking (i.e., potable alcohol), or other biochemicals or biomaterials.
- a fermentation process designed to produce alcohol for fuel or drinking (i.e., potable alcohol), or other biochemicals or biomaterials.
- One skilled in the art is aware of various fermentation conditions that may be used in the production of these end-products. These various uses of alpha-amylases are described in more detail below.
- a useful starch substrate may be obtained from tubers, roots, stems, legumes, cereals or whole grain. More specifically, the granular starch may be obtained from com, cobs, wheat, barley, rye, triiicale, rnilo, sago, millet, cassava, tapioca, sorghum, rice, peas, bean, banana, or potatoes.
- Com contains about 60-68% starch; barley contains about 55-65% starch; millet contains about 75-80% starch; wheat contains about 60-65% starch; and polished rice contains 70-72% starch.
- contemplated starch substrates are com starch and wheat starch.
- the starch from a grain may be ground or whole and includes corn solids, such as kernels, bran and/or cobs.
- the starch may also be highly refined raw starch or feedstock from starch refinery processes.
- Various starches also are commercially available.
- corn starch is available from Cerestar, Sigma, and Katayama Chemical Industr' Co. (Japan); wheat starch is available from Sigma; sweet potato starch is available from Wako Pure Chemical Industry' Co. (Japan); and potato starch is available from Nakaari Chemical Pharmaceutical Co. (Japan).
- the starch substrate can be a crude starch from milled whole grain, which contains non-starch fractions, e.g., germ residues and fibers.
- Milling may comprise wet milling or dry milling or grinding. In wet milling, whole grain is soaked in water or dilute acid to separate the grain into its component parts, e.g., starch, protein, germ, oil, kernel fibers. Wet milling efficiently separates the germ and meal (i.e., starch granules and protein) and is especially suitable for production of syrups.
- Starch to be processed may be a highly refined starch quality, for example, at least 90%, at least 95%, at least 97%, or at least 99.5% pure.
- the term“liquefaction’' or“liquefy” means a process by which gelatinized starch is converted to less viscous liquid containing shorter chain soluble dextrins, liquefaction-inducing and/or saccharifying enzymes optionally may be added.
- the starch substrate prepared as described above is slurried with water.
- the starch slurry' may contain starch as a weight percent of dry' solids of about 10-55%, about 20- 45%, about 30-45%, about 30-40%, or about 30-35%.
- Alpha- Amylase (EC 3.2.1.1) may be added to the slurry, with a metering pump, for example.
- Tire alpha- amylase typically used for this application is a thermal stable, bacterial alpha- amylase, such as a Geobacillus stearothermophiius alpha- amylase, CytophagajApha- amylase, etc, for example SPEZYME® RSL (DuPont product), SPEZYME® AA (DuPont product), SPEZYME® Fred (DuPont product), CLEARFLOW® AA (DuPont product), SPEZYME® Alpha PF (DuPont product), SPEZYME® Powerliq (DuPont product) can be used here.
- the alpha-amylase may be supplied, for example, at about 1500 units per kg dry matter of starch.
- the pH of the slurry typically is adjusted to about pH 5.5- 6 5 or a pFI most suitable for the amylase to be added and about 1 rnM of calcium (about 40 ppm free calcium ions) can also be added.
- Various alpha-amylases may require different conditions. Liquefaction alpha-amylase remaining in the slurry following liquefaction may be deactivated via a number of methods, including lowering the pH in a subsequent reaction step or by removing calcium from the slurry' in cases where the enzyme is dependent upon calcium.
- the slurry of starch plus the alpha- amylase may be pumped continuously through a jet cooker, which is steam heated to 80-1 10°C, depending upon the source of the starch containing feedstock. Ge!atinization occurs rapidly under these conditions, and the enzymatic activity, combined with the significant shear forces, begins the hydrolysis of the starch substrate. The residence time m the jet cooker is brief.
- the partially gelatinized starch may then he passed into a series of holding tubes maintained at 105-1 10°C and held for 5-8 min. to complete the ge!atinization process (“primary liquefaction”). Hydrolysis to the required DE is completed in holding tanks at 85-95°C or higher temperatures for about 1 to 2 hours (“secondary liquefaction”).
- the term“minutes of secondary' liquefaction” refers to the time that has elapsed from the start of secondary liquefaction to the time that the Dextrose Equivalent (DE) is measured.
- the slurry is then allowed to cool to room temperature. This cooling step can be 30 minutes to 180 minutes, e.g. 90 minutes to 120 minutes.
- the liquefied starch typically is in the form of a slurry' having a dry solids content (w/w) of about 10-50%; about 10-45%; about 15-40%; about 20-40%; about 25-40%; or about 25-35%.
- Liquefaction with alpha-amylases advantageously can be conducted at low pH, eliminating the requirement to adjust the pH to about pFT 5.5-6.5.
- Alpha-amylases can be used for liquefaction at a pH range of 2 to 7, e.g. , pH 3.0 - 7 5, pH 4.0 - 6.0, or pH 4.5 - 5.8.
- Alpha-amylases can maintain liquefying activity at a temperature range of about 70°C - 140°C, e.g., 85°C, 90°C, or 95°C.
- liquefaction can be conducted with 800 pg an amylase in a solution of 25% DS com starch for 10 min at pH 5.8 and 85°C, or pH 4.5 and 95°C.
- Liquefying activity can be assayed using any of a number of known viscosity assay methods in the art.
- startch liquifacti on is performed at a temperature range of 90-115°C, for the purpose of producing high-purity glucose syrups, HFCS, maltodextnns, etc.
- the liquefied starch may be saccharified into a syrup rich in lower DP (e.g., DP I + DP2) saccharides, using alpha-amylases, optionally in the presence of another enzyme(s).
- DP e.g., DP I + DP2
- alpha-amylases optionally in the presence of another enzyme(s).
- the exact composition of the products of saccharification depends on the combination of enzymes used, as well as the type of starch processed.
- the syrup obtainable using the provided alpha-amylases may contain a weight percent of DP2 of the total oligosaccharides in the saccharified starch exceeding 30%, e.g , 45% - 65% or 55% - 65%.
- the weight percent of (DPI + DP2) in the saccharified starch may exceed about 70%, e.g., 75% - 85% or 80% - 85%.
- the present amylases also produce a relatively high yield of glucose, e.g., DPI > 20%, in the syrup product.
- Saccharification is often conducted as a batch process. Saccharification conditions are dependent upon the nature of the hquefact and type of enzymes available. In some cases, a saccharification process may involve temperatures of about 60-65°C and a pH of about 4.0-4.5, e.g., pH 4.3. Saccharification may be performed, for example, at a temperature between about 40°C, about 50°C, or about 55°C to about 60°C or about 65°C, necessitating cooling of the Liquefact. The pH may also be adjusted as needed. Saccharification is normally conducted in stirred tanks, which may take several hours to fill or empty.
- Enzymes typically are added either at a fixed ratio to dried solids, as the tanks are filled, or added as a single dose at the commencement of the filling stage.
- a saccharification reaction to make a syrup typically is run over about 24-72 hours, for example, 24-48 hours.
- the reaction is stopped by heating to 85 °C for 5 min., for example. Further incubation will result in a lower DE, eventually to about 90 DE, as accumulated glucose re-polymerizes to isomaltose and/or other reversion products via an enzymatic reversion reaction and/or with the approach of thermodynamic equilibrium.
- saccharification optimally is conducted at a temperature range of about 30°C to about 75°C, e.g., 45°C - 75°C or 47°C - 75°C.
- the saccharifying may be conducted over a pH range of about pH 3 to about pH 7, e.g., pH 3.0 - pH 6 5, pH 3 5 - pH 5.5, pH 3.5, pH 3.8, or pH 4 5.
- An amylase may be added to the slurry in the form of a composition.
- Amylase can be added to a slurry' of a granular starch substrate.
- An amylase can be added as a whole broth, clarified, enriched, partially purified, or purified enzyme.
- the amylase also can be added as a whole broth product.
- An amylase may be added to the slurry as an isolated enzyme solution.
- an amylase can be added in the form of a cultured cell material produced by host cells expressing such amylase.
- An amylase may also be secreted by a host cell into the reaction medium during the fermentation or SSF process, such that the enzyme is provided continuously into the reaction.
- the host cell producing and secreting amylase may also express an additional enzyme, such as a glucoamylase.
- U.S. Patent No. 5,422,267 discloses the use of a glucoamylase in yeast for production of alcoholic beverages.
- a host ceil e.g., Trichoderma reesei or Aspergillus niger, Myceliopthora thermophila or Yeast
- a host ceil may be engineered to co-express an amylase and a glucoamylase, e.g., Humicola GA, Trichoderma GA, or variants of these, during saccharification.
- the host cell can be genetically modified so as not to express its endogenous glucoamylase and/or other enzymes, proteins or other materials.
- the host cell can be engineered to express a broad spectrum of various saccharolytic enzymes.
- the recombinant yeast host cell can comprise nucleic acids encoding a glucoamylase, an a!pha-g!ucosidase, beta-amylase, an enzyme that utilizes pentose sugar, an alpha- amylase, a pulluianase, an isoamylase, an isopullulanase, a phytase, a protease, and/or other enzymes. See, e.g. , WO 201 1/153516 A2,
- the present alpha- amylases can also be used in a granular or raw starch hydrolysis (RSH) or granular starch hydrolysis (GSH) process for producing desired sugars and fermentation products.
- granular starch means raw uncooked starch, i. e., starch in its natural form found in cereal, tubers or grains.
- a "raw starch hydrolysis” process (RSH) differs from conventional starch treatment processes, including liquefying gelatinized starch at high temperature using typically a bactenal alpha-amylase, followed by simultaneous saccharification and fermentation carried out in the presence of a glucoamylase and a fermentation organism and possibly other enzymes.
- RSH process includes sequentially or simultaneously saccharifying and fermenting granular starch at or below the gelatinization temperature of the starch substrate typically in the presence of at least an amylase and/or glucoamylase.
- the gelatinization temperature may vary according to the plant species, to the particular variety of the plant species as well as with the growth conditions.
- a fungal alpha-amylase described herein expressed in bacterial, fungal, yeast or ethanologenic microbial cells can be used in raw starch hydrolysis process described herein.
- alpha-amylase that is other than the alpha-amylase described in this invention, glucoamylase, hexokmase, xylanase, glucose isomerase, xylose isomerase, phosphatase, phytase, pullulanase, beta-amylase, protease, cellulase, hemicellulase, lipase, cutinase, isoamylase, redox enzyme, esterase, transferase, peciinase, a-glucosidase, beta- glucosidase, or a combination thereof can also be used in raw starch hydrolysis process described herein.
- the said enzymes can be co-expressed with alpha-amylase in this invention or directly added into the raw starch hy drolysis process.
- the soluble starch hydrolysate can be fermented by contacting the starch hydrolysate with a fermenting organism typically at a temperature around 32°C, such as from 30°C to 35°C for alcohol-producing yeast.
- a fermenting organism typically at a temperature around 32°C, such as from 30°C to 35°C for alcohol-producing yeast.
- the temperature and pH of the fermentation will depend upon the fermenting organism.
- End of fermentation (EOF) products include metabolites, such as citric acid, lactic acid, succinic acid, monosodium glutamate, gluconic acid, sodium gluconate, calcium gluconate, potassium gluconate, itaconic acid and other carboxylic acids, glucono delta-lactone, sodium erythorbate, amino acids, lysine and other amino acids, vitamins, omega 3 fatty acid, butanol, isoprene, 1,3-propanediol, vitamins, and other biomaterials.
- metabolites such as citric acid, lactic acid, succinic acid, monosodium glutamate, gluconic acid, sodium gluconate, calcium gluconate, potassium gluconate, itaconic acid and other carboxylic acids, glucono delta-lactone, sodium erythorbate, amino acids, lysine and other amino acids, vitamins, omega 3 fatty acid, butanol, isoprene, 1,3-
- Ethanologenic microorganisms include yeast, such as Saccharomyces cerevisiae and bacteria, e.g., Zymomonas moolis, expressing alcohol dehydrogenase and pyruvate decarboxylase.
- the ethanologenic microorganism can express xylose reductase and xylitol dehydrogenase, which convert xylose to xylulose.
- Improved strains of ethanologenic microorganisms which can withstand higher temperatures, for example, are known in the art and can be used. See Liu el al. (2011) Sheng Wu Gong Cheng Xue Bao 27: 1049-56.
- yeast Commercial sources of yeast include ETHANOL RED ® (LeSaffre); THERMOS ACC ⁇ (Lallemand); RED STAR® (Red Star); FERMIOL® (DSM Specialties); and SUPERSTART® (Alltech).
- Microorganisms that produce other metabolites, such as citric acid and lactic acid, by fermentation are also known m the art. See, e.g., Papagianni (2007) Biotechnol. Adv. 25:244-63; John et al. (2009) Biotechnol. Adv. 27:145-52.
- the saccharification and fermentation processes may be earned out as an SSF process. Fermentation may comprise subsequent enrichment, purification, and recovery ' of ethanol, for example.
- the ethanol content of the broth or“beer” may reach about 8-18% v/v, e.g., 14-15% v/v.
- the broth may be distilled to produce enriched, e.g., 96% pure, solutions of ethanol.
- CO2 generated by fermentation may be collected with a CO2 scrubber, compressed, and marketed for other uses, e.g. , carbonating beverage or dry ice production.
- Solid waste from the fermentation process may be used as protem-rich products, e.g., livestock feed.
- an SSF process can be conducted with fungal cells that express and secrete amylase continuously throughout SSF.
- the fungal cells expressing amylase also can be the fermenting microorganism, e.g., an ethanologenic microorganism. Ethanol production thus can be carried out using a fungal cell that expresses sufficient amylase so that less or no enzyme has to be added exogenously.
- the fungal host cell ca be from an appropriately engineered fungal strain. Fungal host cells that express and secrete other enzymes, in addition to amylase, also can be used.
- Such cells may express glucoamylase and/or a pu!lulanase, phytase, alpha-glucosidase, isoamylase, beta-amylase ce!lulase, xy!anase, other hemicellulases, protease, beta-glucosidase, pectinase, esterase, redox enzymes, transferase, or other enzymes.
- glucoamylase and/or a pu!lulanase phytase, alpha-glucosidase, isoamylase, beta-amylase ce!lulase, xy!anase, other hemicellulases, protease, beta-glucosidase, pectinase, esterase, redox enzymes, transferase, or other enzymes.
- Fermentation products such as ethanol are produced by first degrading starch- containing material into fermentable sugars by liquefaction and saccharification, or liquefaction followed by SSF, or saccharification followed by fermentation (raw starch process), and converting the sugars directly or indirectly into the desired fermentation product using a fermenting organism.
- Liquid fermentation products such as ethanol are recovered from the fermented mash (often referred to as “beer” or “beer mash”), e.g., by distillation, which separates the desired fermentation product from other liquids and/or solids.
- the remaining faction referred to as "whole stillage" is separated into a solid and a liquid phase, e.g., by centrifugation.
- wet cake (or “wet grains” or “WDG”) and the liquid phase (supernatant) is referred to as “thin stillage”.
- Wet cake is dried to provide "Distillers Dried Grains” (DDG) used as nutrient in animal feed.
- DDG Disdens Dried Grains
- Thin stillage is typically evaporated to provide condensate and syrup (or “thick stillage") or may alternatively be recycled directly to the slurry tank as “backset”. Condensate may either be forwarded to a methanator before being discharged or may be recycled to the slurry tank.
- the syrup consisting mainly of limit dextrins and non-fermen table sugars may be blended into DDG or added to the wet cake before drying to produce DDGS (Distillers Dried Grain with Solubles).
- DDGS Danillers Dried Grain with Solubles.
- the oil from the by-products like Whole Stillage, Wet Cake, Thin Stillage, DDG and/or DDGS can be recovered as a separate by-product for use in biodiesel production or other products
- the by-products like DDG, DDGS or WDG comprises proteins, fibers, fat and unconverted starch.
- the Wet-Cake may be used in dairy feedlots.
- the dried DDGs may be used in livestock, e,g, dairy, beef and swine feeds and poultry feeds. While the protein content is high, the amino acid composition is not well suited for monogastric animals if used as animal feed.
- the by-products contain significant levels of Crude Fibers (CF), which are structural carbohydrates consisting of cellulose, hemicellulose and indigestible materials like lignin. The proportion of cellulose and lignin in the crude fibers fraction also determines the digestibility of crude fibers and its solubility in the intestine.
- CF Crude Fibers
- NSP soluble non- starch-polysaccharides
- the soluble NSP can cause an increase in viscosity during fermentation and can influence separation and drying conditions of fermentation by-products like DDGS in the production process.
- the present amylases may be used in these processes, as well as other starch degrading enzymes, such as alpha-amylase that is other than the alpha-amylase described in this invention, glucoamylase, hexokinase, xylanase, glucose isomerase, xylose isomerase, phosphatase, phytase, pullulanase, beta-amylase, protease, cellulase, hemicellulase, lipase, cutinase, isoamylase, redox enzyme, esterase, transferase, pectinase, a-glucosidase, beta-glucosidase, or a combination thereof, even hemicellulases, ce!lulases.
- the enzymes can be added at any step in the process.
- a polypeptide comprising an amino acid sequence that is at least about 90%, at least about 95%, identical to that of SEQ ID NO: 3 can be used in the enzyme composition.
- Alpha-amylases may be combined with a glucoamylase (EC 3.2, 1.3), e.g., a Trichoderma glucoamylase or variant thereof.
- a glucoamylase is Trichoderma reesei glucoamylase (TrGA) and variants thereof that possess superior specific activity and thermal stability. See U.S. Published Applications Nos. 2006/0094080, 2007/0004018, and 2007/0015266 (Danisco US Inc.).
- Suitable variants of TrGA include those with glucoamylase activity and at least 80%, at least 90%, or at least 95% sequence identity to wild-type TrGA.
- Alpha-amylases advantageously increase the yield of glucose produced in a saccharification process catalyzed by TrGA.
- the glucoamylase may be another glucoamylase derived from plants (including algae), fungi, or bacteria.
- the g!ucoamylases may be Aspergillus niger Gl or G2 glucoamylase or its variants (e.g , Boel et al. (1984) EMBO J. 3: 1097-1102; WO 92/00381; WO 00/04136 (Novo Nordisk A/S)); and A. awamori glucoamylase (e.g., WO 84/02921 (Cetus Corp.)).
- Aspergillus glucoamylase include variants with enhanced thermal stability, e.g., G137A and G139A (Chen et al. (1996) Prot. Eng. 9:499-505); D257E and D293E/Q (Chen et al. (1995) Prot. Eng. 8:575-582); N182 (Chen et al. (1994) Biochem. J. 301:275-281 ); A246C (Fierobe et al. (1996) Biochemistry , 35: 8698-8704); and variants with Pro residues in positions A435 and S436 (Li et al. (1997) Protein Eng. 10:1199- 1204).
- G137A and G139A Choen et al. (1996) Prot. Eng. 9:499-505)
- D257E and D293E/Q Choen et al. (1995) Prot. Eng. 8:575-582
- N182 Chen et al
- glucoamylases include Talaromyces glucoamylases, in particular derived from T enter sonii (e.g., WO 99/28448 (Novo Nordisk A'S), T. leycettanus (e.g., U.S. Patent No. RE 32,153 (CPC Internationa], Inc.)), T. duponti, or T. thermophilus (e.g, U.S. Patent No. 4,587,215).
- Contemplated bacterial glucoamylases include glucoamylases from the genus Clostridium , in particular C. thermoamylolyticum (e.g., EP 135138 (CPC International, Inc.) and C.
- thermohydrosulfur icum e.g, WO 86/01831 (Michigan Biotechnology Institute)
- Suitable glucoamylases include the glucoamylases derived from Aspergillus oryzae , such as a glucoamylase shown in SEQ ID NO:2 in WO 00/04136 (Novo Nordisk A/S).
- glucoamylases such as AMG 200L; AMG 300 L; SANTM SUPER and AMGTM E (Novozymes); OPTIDEX® 300 and OPTIDEX L-400 (Damsco US Inc.); AMIGASETM and AM1GASETM PLUS (DSM); G-ZYME® G900 (Enzyme Bio-Systems); and G-ZYME® G990 ZR (A. nige r glucoamylase with a low protease content).
- glucoamylases include Aspergillus furnigaius glucoamylase, Talar omyces glucoamylase, Thielavia glucoamylase, Trametes glucoamylase, Thermomyces glucoamylase, Athelia glucoamylase, Pycnoporus glucoamylase, Penici!lim glucoamylases or Humicola glucoamylase (e.g., HgGA).
- Glucoamylases typically are added in an amount of about 0 1 - 2 glucoamylase units (GAU)/g ds, e.g., about 0.16 GAU/g ds, 0.23 GAU/g ds, or 0.33 GAU/g ds.
- GAU glucoamylase units
- amylase examples include a phytase, protease, pullulanase, beta- amylase, isoamylase, a different alpha-amylase, aipha-giucosidase, ceilulase, xylanase, other hemicellulases, beta-glucosidase, transferase, pectinase, lipase, cutinase, esterase, redox enzymes, or a combination thereof.
- a debranching enzyme such as an isoamylase (EC 3.2.1.68), may be added in effective amounts well known to the person skilled in the art.
- a pullulanase (EC 3.2, 1.41 ), e.g., PROMOZYME®, is also suitable.
- Further suitable enzymes include proteases, such as fungal and bacterial proteases.
- Fungal proteases include those obtained fro Aspergillus , such as A. niger, A. aw amor i, A. oryzae ; Mucor ( e.g., M . miehei ); Rhizopus and Trichoderma.
- Beta-Amylases (EC 3.2.1.2) are exo-acting maltogemc amylases, which catalyze the hydrolysis of 1,4-alpha-glucosidic linkages into amylopectin and related glucose polymers, thereby releasing maltose.
- Beta-Amylases have been isolated from various plants and microorganisms. See Fogarty et al. (1979) in PROGRESS IN INDUSTRIAL MICROBIOLOGY, Vol. 15, pp. 1 12-115. These beta- Amylases have optimum temperatures in the range from 40°C to 65°C and optimum pFi in the range from about 4.5 to about 7.0.
- Contemplated beta-amylases include, but are not limited to, beta- amylases from barley SPEZYME® BBA 1500, SPEZYME® DBA, OPT!MALTTM ME, OPTIMALTTM BBA (Damsco US Inc.); and NOVOZYMTM WBA (Novozymes A/S).
- compositions comprising the present amylases may be aqueous or non-aqueous formulations, granules, powders, gels, slurries, pastes, etc., which may further comprise any one or more of the additional enzymes listed, herein, along with buffers, salts, preservatives, water, co-solvents, surfactants, and the like.
- All references cited herein are herein incorporated by reference in their entirety for all purposes. In order to further illustrate the compositions and methods, and advantages thereof, the following specific examples are given with the understanding that they are illustrative rather than limiting.
- the protein sequence of a fungal alpha-amylase designated AspAmyl4 was identified from an Aspergillus sp. strain based on sequence homology.
- a synthetic gene encoding AspAmy l4 was ordered as a codon-optimized gene for expression in Trichoderma reesei.
- the codon-optimized synthetic gene encoding AspAmyT4 is set forth as SEQ ID NO: 1 :
- the amino acid sequence of the AspAmyM precursor protein is set forth as SEQ ID NO: 2.
- the native signal peptide is shown in italics and underline.
- the plasmid pZKY258 was transformed into a suitable Trichoderma reesei strain (method described in published PCT application WO 05/001036) using protoplast transformation (Te’o et al. (2002) I. Microbiol. Methods 51:393-99). Transformants were selected on a solid medium containing acetamide as the sole source of nitrogen. After 5 days of growth on acetamide plates, transformants were collected and subjected to fermentation in 250 mL shake flasks in defined media containing a mixture of glucose and sophorose.
- the solution was then loaded into a 20 ml HiPrepTM Q FF 16/10 column pre-equilibrated with 20 mM NaPlbPCL (pH 7.0). Elution was performed using 6 column volumes of 0.3 NaCl. Fractions were collected and run on SDS-PAGE. The fractions containing the target protein were pooled, concentrated, and exchanged with the buffer to 20 mM sodium acetate pPT 5.0 using an Arnicon Ultra- 15 device with 10 K MWCO The purified sample is around 90% pure and stored in 40% glycerol at -20 °C until usage.
- Alpha- amylase activity was determined using a colorimetric assay to monitor the release of reducing sugars from potato amylopectin. The activity is reported as equivalents of glucose released per minute.
- Substrate solutions were prepared by mixing 9 mL of 1% (w/w, in water) potato amylopectin (Sigma, Cat. No. 10118), 1 mL of 0.5 M buffer (pH 5.0 sodium acetate or pH 8.0 HEPES), and 40 mE of 0.5 M CaCh into a 15-mL conical tube.
- Stock solution of purified alpha-amylase sample was made by diluting original sample to 20 ppm in water.
- Total reducing sugars present in each well were measured using a PAHBAH method: 80 pL of 0.5 N NaOH was aliquoted into a microtiter plate, followed by the addition of 20 pL of PAHBAH reagent [5% w/v 4- hydroxybenzoic acid hydrazide in 0.5 N HC1] and 10 pL of each reaction mixture. Plates were incubated at 95 °C for 5 min and cooled down at 4 °C for 5 sec. Samples (80 pL) were then transferred to polystyrene microtiter plates (Costar 9017) and absorbance was read at 410 nm.
- Asp Amy 14 showed an optimum temperature at 70 °C and retained greater than 70% of maximum activity between 54 °C and 75°C, whereas AcAA exhibited an optimum temperature of 63 °C arid maintained greater than 70% of maximum activity between 49 °C and 71 °C.
- alpha-amylase AspAmyl4 was determined by measuring the enzyme activity before and after enzyme samples pre-incubated at temperatures from 40 to 90 °C for 2 h. Enzyme was diluted in 50 rnM of sodium acetate buffer (pH 5.0) containing 2 mM of CaCb to 10 ppm and 50 pL was aliquot to PCR strip tubes. The tubes were transferred to PCR machines at the desired temperature from 40 to 90 °C.
- the enzymes were diluted to 2.5 ppm in water and assayed for their residual activities using the amylopectin/PAHBAH method as described in Example 4
- the residual activities were converted to percentages of relative activity, by defining the activity of the sample kept on ice as 100%.
- the thermostability' was defined as the temperature at winch the sample remained 50% of activity.
- AspAmy14 retained greater than 60% of initial activity after 2 h incubation at 60°C, whereas AcAA only maintained 5% residual activity under the same incubation conditions. Thermostability of Asp Amy 14 and AcAA
- [QQ132] SSF is typically conducted at pH 3.8-4.8, 32 °C for 55 hours, and the enzymes used m the process should be able to maintain its activity under this condition during the whole process. Thus, it is very' useful to know the low' pH stability of the enzymes. Hie pH stability is evaluated by measuring the residual enzyme activity after preincubating the enzyme at pH 3.7 and pH 4.5, respectively, for a determined length of time. Residual enzyme activity' is assayed using the amyiopectin/PAHBAH method as described in Example 4. Enzyme stock solutions were prepared by diluting the samples to 400 ppm in water and stored at 4 °C.
- the goal of starch solubilization assay is to evaluate the enzyme capability of removing insoluble residual starch by measuring the remaining insoluble starch at the end of the assay. This is performed by determining the optical density (QD) of each well at 260 nm. The large starch granules will scatter the light passing through the well; therefore the higher concentration of insoluble starch, the higher the OD.
- the substrate for solubilization assay was a blend of amyloge! (70% amylose content Hylon VII) and insoluble com starch (Sigma- aldrich, Batch #: 129K0076) which mimics the real substrate used in SSF.
- the solubilization substrate 150 pL was mixed well (stirring) while it w3 ⁇ 4s added to the UV/'vis plate (MTP, Coming 3635). Wide bore tips were required for transferring substrate.
- the enzyme solution (10 pL) was added to each well with final concentration from 0 to 12.5 ppm.
- the plate was then incubated for 24 hours at 32 °C while shaking at 250 rpm. After 24 hours, the plate w3 ⁇ 4s briefly mixed to make sure that the particles w3 ⁇ 4re suspended. Then the plate was read at 260 nm.
- AspAmyM showed better performance compared to AcAA in terms of insoluble starch removal at both pH 3.7 and 4.5, especially at the lower enzyme dosages.
- Asp Amy 14 and AcAA were evaluated for their performance under conditions (at pH 4.4, 32 ⁇ C) meant to represent industrial simultaneous sacharifi cation and fermentation (SSF) conditions.
- Com liquefact 34.85% dry solids
- H2SO4 was added to adjust the pH to 4.4 and solid urea was added to 600 ppm.
- Dry yeast (Ethanol Red, Lesaffre Advanced Fermentations, France, #42138) was hydrated by adding 1 g to 4 ml water and incubated for 10 min before resuspension and addition to the liquefact at a dilution of 1:200.
- the liquefact (0.4 ml) was added to each well of a 96- deepwell microtiter plate containing a protease (Fermgen, Dupont, 0.124 SAPU/'g dry' solids), a T. reesei giucoamylase variant (3.5 pg/g dry solid) and an alpha-amylase (0-36 pg/g dry solids).
- the plate was sealed to allow' gas to escape but not to enter the wells, and placed in a forced-air incubator at 32 DC shaking at 300 rpm.
- SAPU One spectrophotometric acid protease unit (SAPU) is the enzyme activity that will liberate lpmol of tyrosine per minute under the conditions specified (pH 3.0 and 37°C). The assay is based on the enzymatic hydrolysis of a casein substrate in which the solubilized casein filtrate is determined spectrophotometrically.
Abstract
Description
Claims
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2017110873 | 2017-11-14 | ||
PCT/US2018/059321 WO2019099235A1 (en) | 2017-11-14 | 2018-11-06 | Alpha-amylase, composition and method |
Publications (1)
Publication Number | Publication Date |
---|---|
EP3710580A1 true EP3710580A1 (en) | 2020-09-23 |
Family
ID=64427228
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP18807505.5A Pending EP3710580A1 (en) | 2017-11-14 | 2018-11-06 | Alpha-amylase, composition and method |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP3710580A1 (en) |
CN (1) | CN111989400A (en) |
BR (1) | BR112020009525A2 (en) |
WO (1) | WO2019099235A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2023225459A2 (en) | 2022-05-14 | 2023-11-23 | Novozymes A/S | Compositions and methods for preventing, treating, supressing and/or eliminating phytopathogenic infestations and infections |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5534046A (en) | 1978-09-01 | 1980-03-10 | Cpc International Inc | Novel glucoamyrase having excellent heat resistance and production |
NO840200L (en) | 1983-01-28 | 1984-07-30 | Cefus Corp | GLUCOAMYLASE CDNA. |
US4536477A (en) | 1983-08-17 | 1985-08-20 | Cpc International Inc. | Thermostable glucoamylase and method for its production |
US5422267A (en) | 1984-05-22 | 1995-06-06 | Robert R. Yocum | Industrial yeast comprising an integrated glucoamylase gene |
US4587215A (en) | 1984-06-25 | 1986-05-06 | Uop Inc. | Highly thermostable amyloglucosidase |
US4628031A (en) | 1984-09-18 | 1986-12-09 | Michigan Biotechnology Institute | Thermostable starch converting enzymes |
DK122686D0 (en) | 1986-03-17 | 1986-03-17 | Novo Industri As | PREPARATION OF PROTEINS |
US5223409A (en) | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
DE69107455T3 (en) | 1990-05-09 | 2004-09-23 | Novozymes A/S | A CELLULASE PREPARATION CONTAINING AN ENDOGLUCANASE ENZYME. |
US5162210A (en) | 1990-06-29 | 1992-11-10 | Iowa State University Research Foundation | Process for enzymatic hydrolysis of starch to glucose |
IL99552A0 (en) | 1990-09-28 | 1992-08-18 | Ixsys Inc | Compositions containing procaryotic cells,a kit for the preparation of vectors useful for the coexpression of two or more dna sequences and methods for the use thereof |
DK0562003T4 (en) | 1990-12-10 | 2015-07-13 | Danisco Us Inc | Improved saccharification of cellulose by cloning and amplification of.-Glucosidase gene from Tricodermareesei |
DE4343591A1 (en) | 1993-12-21 | 1995-06-22 | Evotec Biosystems Gmbh | Process for the evolutionary design and synthesis of functional polymers based on shape elements and shape codes |
US5605793A (en) | 1994-02-17 | 1997-02-25 | Affymax Technologies N.V. | Methods for in vitro recombination |
DK1032654T3 (en) | 1997-11-26 | 2009-05-11 | Novozymes As | Thermostable glucoamylase |
MXPA01000352A (en) | 1998-07-15 | 2002-06-04 | Novozymes As | Glucoamylase variants. |
ES2371362T3 (en) | 2003-05-29 | 2011-12-30 | Genencor International, Inc. | NEW GENES OF TRICHODERMA. |
US7413887B2 (en) | 2004-05-27 | 2008-08-19 | Genecor International, Inc. | Trichoderma reesei glucoamylase and homologs thereof |
CA2673525C (en) * | 2006-12-21 | 2017-12-05 | Verenium Corporation | Amylases and glucoamylases, nucleic acids encoding them and methods for making and using them |
US8592194B2 (en) | 2007-10-09 | 2013-11-26 | Danisco Us Inc. | Glucoamylase variants with altered properties |
WO2010091221A1 (en) * | 2009-02-06 | 2010-08-12 | Novozymes A/S | Polypeptides having alpha-amylase activity and polynucleotides encoding same |
CN103124783A (en) | 2010-06-03 | 2013-05-29 | 马斯科马公司 | Yeast expressing saccharolytic enzymes for consolidated bioprocessing using starch and cellulose |
WO2013169645A1 (en) | 2012-05-11 | 2013-11-14 | Danisco Us Inc. | Use of alpha-amylase from aspergillus clavatus for saccharification |
US9765317B2 (en) | 2012-12-17 | 2017-09-19 | Novozymes A/S | Alpha-amylases and polynucleotides encoding same |
CN104903461A (en) * | 2012-12-20 | 2015-09-09 | 丹尼斯科美国公司 | Method of using [alpha]-amylase from aspergillus terreus and pullulanase for saccharification |
CN105916981A (en) | 2013-07-29 | 2016-08-31 | 丹尼斯科美国公司 | Variant enzymes |
US20170321237A1 (en) * | 2014-12-01 | 2017-11-09 | Novozymes A/S | Improved Production of Glucose Syrups |
-
2018
- 2018-11-06 CN CN201880086232.XA patent/CN111989400A/en active Pending
- 2018-11-06 BR BR112020009525-7A patent/BR112020009525A2/en unknown
- 2018-11-06 EP EP18807505.5A patent/EP3710580A1/en active Pending
- 2018-11-06 WO PCT/US2018/059321 patent/WO2019099235A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2019099235A1 (en) | 2019-05-23 |
BR112020009525A2 (en) | 2020-11-03 |
CN111989400A (en) | 2020-11-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2297313B1 (en) | Variant alpha-amylases from bacillus subtilis and methods of use, thereof | |
EP2291526B1 (en) | Saccharification enzyme composition with Bacillus subtilis alpha-amylase | |
CN105722989B (en) | Trehalase in fermentation | |
EP2461702B1 (en) | Alpha-amylase blend for starch processing and method of use thereof | |
US7998709B2 (en) | Process of producing a starch hydrolysate | |
JP5419303B2 (en) | Alpha amylase mixture and method of using the mixture | |
AU2005319073A1 (en) | Polypeptides having glucoamylase activity and polynucleotides encoding same | |
WO2015035914A1 (en) | Processes for producing fermentation products | |
JP2023527266A (en) | Glucoamylase and method of use thereof | |
WO2015066669A1 (en) | Proteases in corn processing | |
WO2015021601A1 (en) | Simultanenous liquifaction and malto-saccharification | |
WO2015094714A1 (en) | Proteases in grain processing | |
WO2009114403A1 (en) | Use of rhizopus amylases in granular starch hydrolysis | |
AU2022202136A1 (en) | Trehalase in fermentations | |
EP3710580A1 (en) | Alpha-amylase, composition and method | |
US20200277632A1 (en) | Glucoamylase and methods of use, thereof | |
WO2015066667A1 (en) | Proteases in wheat processing | |
US20110039307A1 (en) | Ethanol yields in fermentation from an improved liquefaction process | |
AU2014342553A1 (en) | Trehalase in fermentations |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: UNKNOWN |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20200520 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
P01 | Opt-out of the competence of the unified patent court (upc) registered |
Effective date: 20230530 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
17Q | First examination report despatched |
Effective date: 20240110 |